Epigenetic memory in induced pluripotent stem cells.
- Authors
- Kim, K; Doi, A; Wen, B; Ng, K; Zhao, R; Cahan, P; Kim, J; Aryee, M J; Ji, H; Ehrlich, L I R; Yabuuchi, A; Takeuchi, A; Cunniff, K C; Hongguang, H; McKinney-Freeman, S; Naveiras, O; Yoon, T J; Irizarry, R A; Jung, N; Seita, J; Hanna, J; Murakami, P; Jaenisch, R; Weissleder, R; Orkin, S H; Weissman, I L; Feinberg, A P; Daley, G Q
- Year
- 2010
- Journal
- Nature
- PMID
- 20644535
- DOI
- 10.1038/nature09342
- PMCID
- PMC3150836
Somatic cell nuclear transfer and transcription-factor-based reprogramming revert adult cells to an embryonic state, and yield pluripotent stem cells that can generate all tissues. Through different mechanisms and kinetics, these two reprogramming methods reset genomic methylation, an epigenetic modification of DNA that influences gene expression, leading us to hypothesize that the resulting pluripotent stem cells might have different properties. Here we observe that low-passage induced pluripotent stem cells (iPSCs) derived by factor-based reprogramming of adult murine tissues harbour residual DNA methylation signatures characteristic of their somatic tissue of origin, which favours their differentiation along lineages related to the donor cell, while restricting alternative cell fates. Such an 'epigenetic memory' of the donor tissue could be reset by differentiation and serial reprogramming, or by treatment of iPSCs with chromatin-modifying drugs. In contrast, the differentiation and methylation of nuclear-transfer-derived pluripotent stem cells were more similar to classical embryonic stem cells than were iPSCs. Our data indicate that nuclear transfer is more effective at establishing the ground state of pluripotency than factor-based reprogramming, which can leave an epigenetic memory of the tissue of origin that may influence efforts at directed differentiation for applications in disease modelling or treatment.
Pluripotent stem cells and their characterizationa, Experimental schema. fESC, ntESC, F-iPSC, and B-iPSC were derived from B6/CBA F1 mice by reprogramming and/or cell culture, characterized for pluripotency by criteria applied to human cells, followed by differentiation analysis for osteogenic or hematopoietic lineages. b, Expression of pluripotency markers NANOG and OCT4 by immunohistochemistry. 4,6-Diamidino-2-phenylindole (DAPI) staining for total cell content. Feeder fibroblasts serve as internal negative controls. c, Teratoma analysis: tumor histology from indicated cell lines shows highly cystic structures consisting of differentiated elements of all three embryonic germ layers. Scale bar, 200ΞΌm.
Differentiation of cell linesa, Hematopoietic colony number per 100,000 EB cells differentiated from indicated cell lines. b, Alizarin Red staining of osteogenic cultures of B-iPSC (left) and F-iPSC (right). Top: 3 cm culture dish; Bottom: stained colonies; scale bar, 500 ΞΌm. c, Quantification of elemental calcium by inductively coupled plasma β atomic emission spectroscopy49 in 5Γ105 cells after osteogenic differentiation of indicated cell lines. d, Q-PCR of osteogenic genes, Bglap, Sp7, and Runx2 in indicated cell lines after osteogenic differentiation. Gene expression was normalized to Actin. n=number of independent clones tested. Error bars=s.d.
Analysis of methylation in stem cell linesa, Cluster dendrogram using probes from DMRs that distinguish B-iPSC and F-iPSC. Cell clones are described in Supplemental Table 5. b, Enrichment of DMRs for hematopoiesis and fibroblast-related transcription factors in B-iPSC and F-iPSC, relative to chance (blue histogram; 100,000 random permutations). Left panel: 20 of 74 hematopoiesis-related transcription factors overlap DMRs hypermethylated in F-IPSC (p=0.0034); Right panel: 115 of 764 fibroblast-specific genes overlap DMRs hypermethylated in B-iPSC (p=10β5).
Stringently-defined pluripotent stem cells and their characterizationa, Experimental schema. Four horizontal lines indicate integrated proviruses carrying dox-inducible reprogramming factors in some experiments. Characteristics of individual clones in all subsequent panels can be found in Supplemental Table 5. b, Hematopoietic colony number per 100,000 EB cells differentiated from indicated cell lines. n=number of independent clones tested. Error bars=s.d., added for clones repeated three or more times. c, Cluster dendrogram using probes from DMRs that distinguish Bl-iPSC and NP-iPSC.
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Altered genome induced immune response of iPSCs. | Requena Osete J et al. | β | 2026 | β |
| A multi-kingdom genetic barcoding system for precise clone isolation. | Ishiguro S et al. | β | 2026 | β |
| Cell models to probe the biological bases of antipsychotic-induced metabolic Syndrome: towards an individual specific approach. | Fiore M et al. | β | 2026 | β |
| Directed differentiation of functional corticospinal-like neurons from endogenous SOX6+/NG2+ cortical progenitors. | Ozkan A et al. | β | 2026 | β |
| Disc-Derived Induced Pluripotent Stem Cells and Environmental Cues for Nucleus Pulposus Regeneration. | Laagland LT et al. | β | 2026 | β |
| Effective Non-Invasive Delivery of Epigenetic Drugs Using Functionalized Accessory Unit Conjugates. | Tashima T | β | 2026 | β |
| Engineering organs-on-a-chip <i>via</i> multi-channel microfluidics. | Qiu J et al. | β | 2026 | β |
| Epigenomic alterations and neural development anomalies in induced pluripotent stem cells from sporadic Alzheimer's disease. | Katbe A et al. | β | 2026 | β |
| Exploring the impact of human pluripotent stem cell heterogeneity on corneal limbal stem cell differentiation outcomes. | Harjuntausta S et al. | β | 2026 | β |
| Human pluripotent stem cell models of Friedreich's ataxia: innovations, considerations, and future perspectives. | Nguyen HT et al. | β | 2026 | β |
| Immunogenicity of induced pluripotent stem cell-derived smooth muscle cells results from a reduction in the expression of indoleamine 2,3 dioxygenase (IDO-1). | Partridge K et al. | β | 2026 | β |
| Implications of genetic and epigenetic aberrations to the tumorigenicity of human pluripotent stem cells. | Keshet G et al. | β | 2026 | β |
| iPSC-Derived Endothelial Cells as Experimental Models for Predictive and Personalized Strategies in Cardiovascular and Cerebrovascular Disease. | Fontanelli L et al. | β | 2026 | β |
| Lineage specification into GABAergic, glutamatergic, dopaminergic, and astrocytic phenotypes using MUSE stem cells: a novel approach for modeling neurodegenerative and psychiatric disorders. | Aprile D et al. | β | 2026 | β |
| Microglia-associated progression of multiple sclerosis: target identification and therapeutic engagement in human in vitro models. | Blenkle A et al. | β | 2026 | β |
| Modeling amyotrophic lateral sclerosis (ALS) <i>in vitro</i>: from mechanistic studies to translatable drug discovery. | Maskell KG et al. | β | 2026 | β |
| Partial Reprogramming Is Conserved from Insect to Mammal. | Tolwinski NS et al. | β | 2026 | β |
| T follicular helper cells transiently unlock a plasticity state in germinal centre B cells during the humoral immune response. | Scourzic L et al. | β | 2026 | β |
| The epigenetic rejuvenation promise: Partial reprogramming as a therapeutic strategy for aging and disease. | Li YY et al. | β | 2026 | β |
| Advances in Induced Pluripotent Stem Cell Reprogramming and Its Application in Amyotrophic Lateral Sclerosis: A Review. | Luo Y et al. | β | 2025 | β |
| Advancing hepatotoxicity assessment: current advances and future directions. | Kim Y et al. | β | 2025 | β |
| Altered Mitochondrial Bioenergetics and Calcium Kinetics in Young-Onset PLA2G6 Parkinson's Disease iPSCs. | Musthafa T et al. | β | 2025 | β |
| Ancestral genomic functional differences in oligodendroglia: implications for Alzheimer's disease. | Ramirez AM et al. | β | 2025 | β |
| A new human <i>in vitro</i> model of cytotypic and testosterone-producing organoids derived from testicular tissue of transgender women. | Madureira Silva S et al. | β | 2025 | β |
| Application potential of induced pluripotent stem cells in the research and treatment of autoimmune diseases (Review). | Ye Z et al. | β | 2025 | β |
| A serum- and feeder-free system to generate CD4 and regulatory T cells from human iPSCs. | Fong H et al. | β | 2025 | β |
| Bone Tissue Engineering: From Biomaterials to Clinical Trials. | Jagadale S et al. | β | 2025 | β |
| Bottom-up Biomaterial strategies for creating tailored stem cells in regenerative medicine. | Cruz-Gonzalez B et al. | β | 2025 | β |
| Building a human pluripotent stem cell-based gonadal niche: improving in vitro systems with in vivo insights. | Lakshmipathi M et al. | β | 2025 | β |
| Can Molecular Attributes of Mammalian Granulosa Cells and Ovarian Putative Stem Cells Predestine Them to Be a Promising Tool for Tissue Engineering and Regenerative Medicine? | Duda M et al. | β | 2025 | β |
| CAR-NK cells: harnessing the power of natural killers for advanced cancer therapy. | Dos Reis FD et al. | β | 2025 | β |
| Cell and tissue reprogramming: Unlocking a new era in medical drug discovery. | Sen CK et al. | β | 2025 | β |
| Challenges and opportunities of human iPSC-derived NK as "Off-the-shelf" cellular therapies. | Romanini N et al. | β | 2025 | β |
| Characterization of Rationally Designed CRISPR/Cas9-Based DNA Methyltransferases with Distinct Methyltransferase and Gene Silencing Activities in Human Cell Lines and Primary Human T Cells. | Guerra-Resendez RS et al. | β | 2025 | β |
| Chromosome-specific epigenetic control and transmission of ribosomal DNA arrays in Hominidae genomes. | Potapova TA et al. | β | 2025 | β |
| Comparative study of CYP450 gene regulation in human pluripotent stem cell-derived liver 2D cell and 3D organoid models. | Kang E et al. | β | 2025 | β |
| Comprehensive Search for Genes Involved in Thalidomide Teratogenicity Using Early Differentiation Models of Human Induced Pluripotent Stem Cells: Potential Applications in Reproductive and Developmental Toxicity Testing. | Kato Y et al. | β | 2025 | β |
| Compromised epigenetic robustness in cancer: fueling evolution, exposing weakness. | Wilson TS et al. | β | 2025 | β |
| Current Development of iPSC-Based Modeling in Neurodegenerative Diseases. | Guo X et al. | β | 2025 | β |
| Deciphering the epigenetic role of KDM4A in pancreatic Ξ²-like cell differentiation from iPSCs. | Arroyave F et al. | β | 2025 | β |
| Efficient and Reproducible Differentiation Protocol for Pluripotent Stem Cells into Functional Endothelial Cells: Unveiling the Path to Vascular Regeneration. | Azhdari M et al. | β | 2025 | β |
| Empagliflozin Reduces High Glucose-Induced Cardiomyopathy in hiPSC-Derived Cardiomyocytes : Glucose-induced Lipotoxicity in hiPSC-Derived Cardiomyocytes. | Tsai HH et al. | β | 2025 | β |
| Enhanced regenerative potential of human dental pulp stem cells for the pulp-dentin complex through coculture with iPSC-derived endothelial cells: An in vitro study. | Cho HM et al. | β | 2025 | β |
| Epigenetic memory as crucial contributing factor in directing the differentiation of human iPSC into pancreatic Ξ²-cells in vitro. | Diane A et al. | β | 2025 | β |
| Generation of Advanced Blood-Brain Barrier Spheroids Using Human-Induced Pluripotent Stem Cell-Derived Brain Capillary Endothelial-Like Cells. | Mathew-Schmitt S et al. | β | 2025 | β |
| Generation of Retinal Ganglion Cells from Reprogrammed Keratocytes of Non-Glaucoma and Glaucoma Donors. | Hameed SS et al. | β | 2025 | β |
| Human organoids and organ-on-chips in coeliac disease research. | Simpson HL et al. | β | 2025 | β |
| Human pluripotent stem cell-derived hepatic progenitors exhibit a partially hypoimmunogenic phenotype and actively inhibit immune responses. | Gantier M et al. | β | 2025 | β |
| IceQream: Quantitative chromosome accessibility analysis using physical TF models. | Bercovich A et al. | β | 2025 | β |
| Induced Pluripotent (iPSC) and Mesenchymal (MSC) Stem Cells for In Vitro Disease Modeling and Regenerative Medicine. | Panferov E et al. | β | 2025 | β |
| Induced Pluripotent Stem Cells-Based Regenerative Therapies in Treating Human Aging-Related Functional Decline and Diseases. | Yu P et al. | β | 2025 | β |
| Interplay between pioneer transcription factors and epigenetic modifiers in cell reprogramming. | Mirizio G et al. | β | 2025 | β |
| Intra-Arterial Stem Cell Injection for Treating Various Diseases: A New Frontier in Interventional Radiology. | Rouzbahani M et al. | β | 2025 | β |
| In vitro erythropoiesis: the emerging potential of induced pluripotent stem cells (iPSCs). | Chukwuemeka CG et al. | β | 2025 | β |
| <i>C9orf72</i> Dipeptide Repeat Proteinopathy Is Linked to Increased Histone H3 Phosphorylation on Serine 10. | Cobos SN et al. | β | 2025 | β |
| Metabolic and Mitochondrial Dysregulations in Diabetic Cardiac Complications. | Tashkandi AJ et al. | β | 2025 | β |
| MicroRNA profiles of four induced pluripotent stem cell lines derived from distinct tissues. | Trakarnsanga K et al. | β | 2025 | β |
| Modelling mitochondrial diseases in neurons <i>In Vitro</i>: A systematic review. | Zarate-Mendez M et al. | β | 2025 | β |
| Neural crest-derived mesenchymal stem cells: Fates and perspectives. | He YL et al. | β | 2025 | β |
| Pluripotent Cells Expressing APOE4 Exhibit a Pronounced Pro-Apoptotic Phenotype Accompanied by Markers of Hyperinflammation and a Blunted NF-ΞΊB Response. | Schulten W et al. | β | 2025 | β |
| Preclinical models for autism spectrum disorder: past, present, and future. | Dwivedi S et al. | β | 2025 | β |
| Regenerative Immunotherapy for Cancer: Transcription Factor Reprogramming of Tumor-Specific T Cells. | McCaw TR et al. | β | 2025 | β |
| Reversion of passaged nucleus pulposus cells to notochordal-type cells by FoxA2 upregulation. | Ashraf S et al. | β | 2025 | β |
| State of the Art of CAR-NK Cell Therapy in Multiple Myeloma: A Comprehensive Review of Cell Sources and Target Antigens. | Bastrich A et al. | β | 2025 | β |
| Synergy between pluripotent stem cell-derived macrophages and self-renewing macrophages: Envisioning a promising avenue for the modelling and cell therapy of infectious diseases. | Peng D et al. | β | 2025 | β |
| Targeting Diabetic Retinopathy with Human iPSC-Derived Vascular Reparative Cells in a Type 2 Diabetes Model. | Li Calzi S et al. | β | 2025 | β |
| Unraveling the Complexity and Advancements of Transdifferentiation Technologies in the Biomedical Field and Their Potential Clinical Relevance. | Mishra P et al. | β | 2025 | β |
| Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer's disease. | CunΓ-LΓ³pez C et al. | β | 2024 | β |
| Advances in induced pluripotent stem cell-derived cardiac myocytes: technological breakthroughs, key discoveries and new applications. | Clancy CE et al. | β | 2024 | β |
| Advancing biomarker development for diagnostics and therapeutics using solid tumour cancer stem cell models. | Wang SSY | β | 2024 | β |
| Avian iPSC Derivation to Recover Threatened Wild Species: A Comprehensive Review in Light of Well-Established Protocols. | Nogueira IPM et al. | β | 2024 | β |
| Bioengineered Organoids Offer New Possibilities for Liver Cancer Studies: A Review of Key Milestones and Challenges. | Jabri A et al. | β | 2024 | β |
| Bridging the Gap: Endothelial Dysfunction and the Role of iPSC-Derived Endothelial Cells in Disease Modeling. | Sgromo C et al. | β | 2024 | β |
| Canine induced pluripotent stem cells can be successfully maintained in weekend-free culture systems. | Kimura K et al. | β | 2024 | β |
| Cell-Based Therapy for Fibrosing Interstitial Lung Diseases, Current Status, and Potential Applications of iPSC-Derived Cells. | Nakamura Y et al. | β | 2024 | β |
| Chromatin-based memory as a self-stabilizing influence on cell identity. | Bell CC et al. | β | 2024 | β |
| Comparison of Natural Killer Cells Differentiated from Various Pluripotent Stem Cells. | Han J et al. | β | 2024 | β |
| Define of Optimal Addition Period of Osteogenic Peptide to Accelerate the Osteogenic Differentiation of Human Pluripotent Stem Cells. | Song Y et al. | β | 2024 | β |
| Disease related changes in ATAC-seq of iPSC-derived motor neuron lines from ALS patients and controls. | Tsitkov S et al. | β | 2024 | β |
| Disruption of common ocular developmental pathways in patient-derived optic vesicle models of microphthalmia. | Eintracht J et al. | β | 2024 | β |
| Enhancing regenerative potential: A comprehensive review of stem cell transplantation for sports-related neuronal injuries, with a focus on spinal cord injuries and peripheral nervous system damage. | Bingnan W et al. | β | 2024 | β |
| Evaluation of mesenchymal stem cells as an <i>in vitro</i> model for inherited retinal diseases. | Dodina M et al. | β | 2024 | β |
| Forward programming of hiPSCs towards beta-like cells using Ngn3, Pdx1, and MafA. | Jeyagaran A et al. | β | 2024 | β |
| Glial-restricted progenitor cells: a cure for diseased brain? | Rogujski P et al. | β | 2024 | β |
| Incomplete reprogramming of DNA replication timing in induced pluripotent stem cells. | Edwards MM et al. | β | 2024 | β |
| Induced Pluripotent Stem Cells as a Possible Approach for Exploring the Pathophysiology of Polycystic Ovary Syndrome (PCOS). | Khatun M et al. | β | 2024 | β |
| Induced pluripotent stem cells derived renal tubular cells from a patient with pseudohypoparathyroidism and its response to parathyroid hormone stimulation. | Nakamura Y et al. | β | 2024 | β |
| Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications. | Cerneckis J et al. | β | 2024 | β |
| Induction of human stem cells into ameloblasts by reaggregation strategy. | Lin C et al. | β | 2024 | β |
| <i>OGT</i> and <i>OGA</i> gene-edited human induced pluripotent stem cells for dissecting the functional roles of <i>O</i>-GlcNAcylation in hematopoiesis. | Luanpitpong S et al. | β | 2024 | β |
| Manipulating cell fate through reprogramming: approaches and applications. | Yagi M et al. | β | 2024 | β |
| Mitochondrial and Cellular Function in Fibroblasts, Induced Neurons, and Astrocytes Derived from Case Study Patients: Insights into Major Depression as a Mitochondria-Associated Disease. | Cardon I et al. | β | 2024 | β |
| Modeling Alzheimer's disease using human cell derived brain organoids and 3D models. | Fernandes S et al. | β | 2024 | β |
| Modeling inherited retinal diseases using human induced pluripotent stem cell derived photoreceptor cells and retinal pigment epithelial cells. | Seah I et al. | β | 2024 | β |
| Multiscale engineering of brain organoids for disease modeling. | Xu C et al. | β | 2024 | β |
| Narrative review of proximal tubular epithelial cell<i>in-vitro</i>co-culture models. | Varda L et al. | β | 2024 | β |
| Pros and Cons of Human Brain Organoids to Study Alzheimer's Disease. | Sainz A et al. | β | 2024 | β |
| Recent trends in 3D bioprinting technology for skeletal muscle regeneration. | Sabetkish S et al. | β | 2024 | β |
| Remyelination in the Central Nervous System. | Franklin RJM et al. | β | 2024 | β |
| Reprogramming of Expanded Cord Blood-Derived CD34<sup><b>+</b></sup> Cells from Umbilical Cord-Mesenchymal Stromal Cell Co-Culture to Generate Human-Induced Pluripotent Stem Cells. | Roslan FF et al. | β | 2024 | β |
| Sall4 and Gata4 induce cardiac fibroblast transition towards a partially multipotent state with cardiogenic potential. | Gao H et al. | β | 2024 | β |
| Scaling Insulin-Producing Cells by Multiple Strategies. | Choi J et al. | β | 2024 | β |
| Source cell-type epigenetic memory persists in induced pluripotent cells but is lost in subsequently derived germline cells. | Lin YH et al. | β | 2024 | β |
| Stem and progenitor cell-based therapy of myelin disorders. | Goldman SA et al. | β | 2024 | β |
| Stem cell-based therapy for fibrotic diseases: mechanisms and pathways. | Taherian M et al. | β | 2024 | β |
| The Efficiency of In Vitro Differentiation of Primate iPSCs into Cardiomyocytes Depending on Their Cell Seeding Density and Cell Line Specificity. | Tereshchenko Y et al. | β | 2024 | β |
| The logic of monsters: development and morphological diversity in stem-cell-based embryo models. | Cao D et al. | β | 2024 | β |
| Therapeutic potential of mesenchymal stem cells from human iPSC-derived teratomas for osteochondral defect regeneration. | Kim J et al. | β | 2024 | β |
| The role of DNA methylation in chondrogenesis of human iPSCs as a stable marker of cartilage quality. | Hajmousa G et al. | β | 2024 | β |
| The Role of Human-Induced Pluripotent Stem Cells in Studying Cardiac Channelopathies. | Begovic M et al. | β | 2024 | β |
| TMEM182 inhibits myocardial differentiation of human iPS cells by maintaining the activated state of Wnt/Ξ²-catenin signaling through an increase in ILK expression. | Morihara H et al. | β | 2024 | β |
| Transcription Factors in Brain Regeneration: A Potential Novel Therapeutic Target. | Marzoog BA | β | 2024 | β |
| Zika virus vertical transmission induces neuroinflammation and synapse impairment in brain cells derived from children born with Congenital Zika Syndrome. | Benazzato C et al. | β | 2024 | β |
| Adoptive Immunotherapy: A Human Pluripotent Stem Cell Perspective. | Jin G et al. | β | 2023 | β |
| A live-cell image-based machine learning strategy for reducing variability in PSC differentiation systems. | Yang X et al. | β | 2023 | β |
| An Example of Neuro-Glial Commitment and Differentiation of Muse Stem Cells Obtained from Patients with <i>IQSEC2</i>-Related Neural Disorder: A Possible New Cell-Based Disease Model. | Al Sammarraie SHA et al. | β | 2023 | β |
| Apoptosis inhibition enhances induced pluripotent stem cell generation during T cell reprogramming. | Ren J et al. | β | 2023 | β |
| Assessment of Fallopian Tube Epithelium Features Derived from Induced Pluripotent Stem Cells of Both Fallopian Tube and Skin Origins. | Chang YH et al. | β | 2023 | β |
| Bridging the translational gap: what can synaptopathies tell us about autism? | Molloy CJ et al. | β | 2023 | β |
| Cell-based experimental strategies for myelin repair in multiple sclerosis. | Borda M et al. | β | 2023 | β |
| Cell-type dependent regulation of pluripotency and chromatin remodeling genes by hydralazine. | Aguirre-VΓ‘zquez A et al. | β | 2023 | β |
| Chemical genomics reveals targetable programs of human cancers rooted in pluripotency. | Orlando L et al. | β | 2023 | β |
| Chemical Transdifferentiation of Somatic Cells: Unleashing the Power of Small Molecules. | Zhang Y et al. | β | 2023 | β |
| Clinical Potential of Cellular Material Sources in the Generation of iPSC-Based Products for the Regeneration of Articular Cartilage. | Eremeev A et al. | β | 2023 | β |
| Comparative analysis of the cardiomyocyte differentiation potential of induced pluripotent stem cells reprogrammed from human atrial or ventricular fibroblasts. | Wang L et al. | β | 2023 | β |
| Comparison of osteoclast differentiation protocols from human induced pluripotent stem cells of different tissue origins. | BlΓΌmke A et al. | β | 2023 | β |
| Connecting the dots: Melanoma cell of origin, tumor cell plasticity, trans-differentiation, and drug resistance. | Castro-PΓ©rez E et al. | β | 2023 | β |
| Corneal Endothelial-like Cells Derived from Induced Pluripotent Stem Cells for Cell Therapy. | Ng XY et al. | β | 2023 | β |
| CTCF deletion alters the pluripotency and DNA methylation profile of human iPSCs. | Puri D et al. | β | 2023 | β |
| Current developments and therapeutic potentials of exosomes from induced pluripotent stem cells-derived mesenchymal stem cells. | Aldoghachi AF et al. | β | 2023 | β |
| Differential chondrogenic differentiation between iPSC derived from healthy and OA cartilage is associated with changes in epigenetic regulation and metabolic transcriptomic signatures. | Khan NM et al. | β | 2023 | β |
| Different iPSC-derived neural stem cells shows various spectrums of spontaneous differentiation during long term cultivation. | Galiakberova AA et al. | β | 2023 | β |
| DNA methylation in the mouse cochlea promotes maturation of supporting cells and contributes to the failure of hair cell regeneration. | Nguyen JD et al. | β | 2023 | β |
| DNA Methylation Signature of Aging: Potential Impact on the Pathogenesis of Parkinson's Disease. | Yazar V et al. | β | 2023 | β |
| Engineered T cells from induced pluripotent stem cells: from research towards clinical implementation. | Netsrithong R et al. | β | 2023 | β |
| Epigenetic modulation of cell fate during pancreas development. | Bele S et al. | β | 2023 | β |
| Evaluation of 2D and 3D Erythroid Differentiation Protocols Using Sickle Cell Disease and Healthy Donor Induced Pluripotent Stem Cells. | Martins GLS et al. | β | 2023 | β |
| From 2D to 3D: Development of Monolayer Dopaminergic Neuronal and Midbrain Organoid Cultures for Parkinson's Disease Modeling and Regenerative Therapy. | Yeap YJ et al. | β | 2023 | β |
| Generation and Functional Characterization of Anti-CD19 Chimeric Antigen Receptor-Natural Killer Cells from Human Induced Pluripotent Stem Cells. | Klaihmon P et al. | β | 2023 | β |
| Generation of Rh D-negative blood using CRISPR/Cas9. | Xu L et al. | β | 2023 | β |
| Human Endometrium Derived Induced Pluripotent Stem Cells Are Amenable to Directed Erythroid Differentiation. | Kim HK et al. | β | 2023 | β |
| Human induced pluripotent stem cell-derived liver-on-a-chip for studying drug metabolism: the challenge of the cytochrome P450 family. | Tamargo-Rubio I et al. | β | 2023 | β |
| Induced pluripotent stem cell technology in bone biology. | Kidwai FK et al. | β | 2023 | β |
| In vitro erythrocyte production using human-induced pluripotent stem cells: determining the best hematopoietic stem cell sources. | Cho YK et al. | β | 2023 | β |
| iPSC-Derived Corneal Endothelial Cells. | Zhou Q et al. | β | 2023 | β |
| iPSC-derived organ-on-a-chip models for personalized human genetics and pharmacogenomics studies. | Palasantzas VEJM et al. | β | 2023 | β |
| Isotopic Tracing of Nucleotide Sugar Metabolism in Human Pluripotent Stem Cells. | Conte F et al. | β | 2023 | β |
| Modeling brain and neural crest neoplasms with human pluripotent stem cells. | Schloo C et al. | β | 2023 | β |
| Modeling diabetic endothelial dysfunction with patient-specific induced pluripotent stem cells. | Gorashi R et al. | β | 2023 | β |
| Modeling of Respiratory Diseases Evolving with Fibrosis from Organoids Derived from Human Pluripotent Stem Cells. | Chamorro-Herrero I et al. | β | 2023 | β |
| Modeling placental development and disease using human pluripotent stem cells. | Morey R et al. | β | 2023 | β |
| New tools can propel research in lysosomal storage diseases. | Hertz E et al. | β | 2023 | β |
| 'Off the shelf' immunotherapies: Generation and application of pluripotent stem cell-derived immune cells. | Wang C et al. | β | 2023 | β |
| Platform-agnostic CellNet enables cross-study analysis of cell fate engineering protocols. | Lo EKW et al. | β | 2023 | β |
| Polystyrene nanoplastics affect transcriptomic and epigenomic signatures of human fibroblasts and derived induced pluripotent stem cells: Implications for human health. | Stojkovic M et al. | β | 2023 | β |
| Potential and Limitations of Induced Pluripotent Stem Cells-Derived Mesenchymal Stem Cells in Musculoskeletal Disorders Treatment. | Dias IX et al. | β | 2023 | β |
| Precision medicine for long QT syndrome: patient-specific iPSCs take the lead. | Yu Y et al. | β | 2023 | β |
| Preferential Hematopoietic Differentiation in Induced Pluripotent Stem Cells Derived From Human Umbilical Cord Arterial Endothelial Cells. | Pei H et al. | β | 2023 | β |
| Recent Emerging Trend in Stem Cell Therapy Risk Factors. | Pourjabbar B et al. | β | 2023 | β |
| Reprogramming of Acute Myeloid Leukemia Patients Cells: Harboring Cancer Mutations Requires Targeting of AML Hierarchy. | Golubeva D et al. | β | 2023 | β |
| SFPQ and Its Isoform as Potential Biomarker for Non-Small-Cell Lung Cancer. | Yang L et al. | β | 2023 | β |
| Small-Caliber Tissue-Engineered Vascular Grafts Based on Human-Induced Pluripotent Stem Cells: Progress and Challenges. | Ji J et al. | β | 2023 | β |
| Stem cell-based strategies and challenges for production of cultivated meat. | Jara TC et al. | β | 2023 | β |
| Supporting materials: Endothelial cells differentiated from patient dermal fibroblast-derived induced pluripotent stem cells resemble vascular malformations of Port Wine Birthmark | Nguyen V et al. | β | 2023 | β |
| Targeting DNA methylation and demethylation in diabetic foot ulcers. | Deng JY et al. | β | 2023 | β |
| The Advantages, Challenges, and Future of Human-Induced Pluripotent Stem Cell Lines in Type 2 Long QT Syndrome. | Cai D et al. | β | 2023 | β |
| The placenta: epigenetic insights into trophoblast developmental models of a generation-bridging organ with long-lasting impact on lifelong health. | Hemberger M et al. | β | 2023 | β |
| Therapeutic strategies to recover ependymal barrier after inflammatory damage: relevance for recovering neurogenesis during development. | Paez-Gonzalez P et al. | β | 2023 | β |
| The role of epigenetic modifications in sensory hair cell development, survival, and regulation. | Xiao Y et al. | β | 2023 | β |
| Tissue-embedded stretchable nanoelectronics reveal endothelial cell-mediated electrical maturation of human 3D cardiac microtissues. | Lin Z et al. | β | 2023 | β |
| Transcription factor-mediated direct cellular reprogramming yields cell-type specific DNA methylation signature. | Horisawa K et al. | β | 2023 | β |
| Transcriptomic analysis of feeder-free culture system for maintaining naΓ―ve-state pluripotency in human pluripotent stem cells. | Isono W et al. | β | 2023 | β |
| Transgenerational Epigenetic DNA Methylation Editing and Human Disease. | Tompkins JD | β | 2023 | β |
| Transient naive reprogramming corrects hiPS cells functionally and epigenetically. | Buckberry S et al. | β | 2023 | β |
| Transition from Animal-Based to Human Induced Pluripotent Stem Cells (iPSCs)-Based Models of Neurodevelopmental Disorders: Opportunities and Challenges. | Guerreiro S et al. | β | 2023 | β |
| Urine-derived cells from the aged donor for the 2D/3D modeling of neural cells via iPSCs. | Supakul S et al. | β | 2023 | β |
| Use and application of organ-on-a-chip platforms in cancer research. | Yu Y et al. | β | 2023 | β |
| Vascular organoids: unveiling advantages, applications, challenges, and disease modelling strategies. | Naderi-Meshkin H et al. | β | 2023 | β |
| Application of the water-insoluble, temperature-responsive block polymer poly(butyl methacrylate-block-N-isopropylacrylamide) for pluripotent stem cell culture and cell-selective detachment. | Kuno G et al. | β | 2022 | β |
| Benefits and Hurdles of Pancreatic Ξ²-Cell Replacement. | Bolla AM et al. | β | 2022 | β |
| Bilirubin-Induced Neurological Damage: Current and Emerging iPSC-Derived Brain Organoid Models. | Pranty AI et al. | β | 2022 | β |
| Characteristic DNA methylation profiles of chorionic villi in recurrent miscarriage. | Matsumoto Y et al. | β | 2022 | β |
| Chromosome silencing inΒ vitro reveals trisomy 21 causes cell-autonomous deficits in angiogenesis and early dysregulation in Notch signaling. | Moon JE et al. | β | 2022 | β |
| Comprehensive comparison of gene expression diversity among a variety of human stem cells. | Yamatani Y et al. | β | 2022 | β |
| Cortical Organoids to Model Microcephaly. | Farcy S et al. | β | 2022 | β |
| Current Application of iPS Cells in the Dental Tissue Regeneration. | Hamano S et al. | β | 2022 | β |
| Current Development, Obstacle and Futural Direction of Induced Pluripotent Stem Cell and Mesenchymal Stem Cell Treatment in Degenerative Retinal Disease. | Chiang MC et al. | β | 2022 | β |
| Cx43 hemichannels contribute to astrocyte-mediated toxicity in sporadic and familial ALS. | Almad AA et al. | β | 2022 | β |
| Deconvoluting the Cells of the Human Heart with iPSC Technology: Cell Types, Protocols, and Uses. | Yu B et al. | β | 2022 | β |
| Defective hematopoietic differentiation of immune aplastic anemia patient-derived iPSCs. | Tellechea MF et al. | β | 2022 | β |
| Determining epigenetic memory in kidney proximal tubule cell derived induced pluripotent stem cells using a quadruple transgenic reprogrammable mouse. | Khelifi G et al. | β | 2022 | β |
| Development of an induced pluripotent stem cell-specific microRNA assay for detection of residual undifferentiated cells in natural killer cell therapy products. | Chung L et al. | β | 2022 | β |
| DNA Methylation Profiles of <i>GAD1</i> in Human Cerebral Organoids of Autism Indicate Disrupted Epigenetic Regulation during Early Development. | Pearson G et al. | β | 2022 | β |
| Downregulating <i>MFN2</i> Promotes the Differentiation of Induced Pluripotent Stem Cells into Mesenchymal Stem Cells through the PI3K/Akt/GSK-3Ξ²/Wnt Signaling Pathway. | Deng L et al. | β | 2022 | β |
| Enhanced Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood and Using Their Mesoderm Differentiation Ability to Regenerate Infarcted Myocardium. | Kim JY et al. | β | 2022 | β |
| Epigenetic regulation of BAF60A determines efficiency of miniature swine iPSC generation. | Jiao H et al. | β | 2022 | β |
| Epigenetics, Enhancer Function and 3D Chromatin Organization in Reprogramming to Pluripotency. | HΓΆrnblad A et al. | β | 2022 | β |
| Epigenetics of childhood trauma: Long term sequelae and potential for treatment. | Thumfart KM et al. | β | 2022 | β |
| From the Dish to the Real World: Modeling Interactions between the Gut and Microorganisms in Gut Organoids by Tailoring the Gut Milieu. | Park NY et al. | β | 2022 | β |
| Generation of hiPSC-Derived Skeletal Muscle Cells: Exploiting the Potential of Skeletal Muscle-Derived hiPSCs. | Metzler E et al. | β | 2022 | β |
| Generation of Lens Progenitor Cells and Lentoid Bodies from Pluripotent Stem Cells: Novel Tools for Human Lens Development and Ocular Disease Etiology. | Cvekl A et al. | β | 2022 | β |
| HOX genes in stem cells: Maintaining cellular identity and regulation of differentiation. | Steens J et al. | β | 2022 | β |
| Human PSCs determine the competency of cerebral organoid differentiation via FGF signaling and epigenetic mechanisms. | Ideno H et al. | β | 2022 | β |
| Induced pluripotent stem cell-based disease modeling and prospective immune therapy for coronavirus disease 2019. | Chakrabarty K et al. | β | 2022 | β |
| Induced Pluripotent Stem Cell-Derived Corneal Cells: Current Status and Application. | Mahmood N et al. | β | 2022 | β |
| Induced pluripotent stem cells: a tool for modeling Parkinson's disease. | Bose A et al. | β | 2022 | β |
| IPSC-Derived Human Neurons with GCaMP6s Expression Allow In Vitro Study of Neurophysiological Responses to Neurochemicals. | Galiakberova AA et al. | β | 2022 | β |
| Kabuki syndrome stem cell models reveal locus specificity of histone methyltransferase 2D (KMT2D/MLL4). | Jefri M et al. | β | 2022 | β |
| Live-cell imaging in human colonic monolayers reveals ERK waves limit the stem cell compartment to maintain epithelial homeostasis. | Pond KW et al. | β | 2022 | β |
| Mesoangioblasts at 20: From the embryonic aorta to the patient bed. | Cossu G et al. | β | 2022 | β |
| Microphysiological Systems: Stakeholder Challenges to Adoption in Drug Development. | Hargrove-Grimes P et al. | β | 2022 | β |
| Modeling hypertrophic cardiomyopathy with human cardiomyocytes derived from induced pluripotent stem cells. | Li J et al. | β | 2022 | β |
| Motor neuron-derived induced pluripotent stem cells as a drug screening platform for amyotrophic lateral sclerosis. | AmorΓ³s MA et al. | β | 2022 | β |
| Moving Towards Induced Pluripotent Stem Cell-based Therapies with Artificial Intelligence and Machine Learning. | Coronnello C et al. | β | 2022 | β |
| Natural killer cells in antitumour adoptive cell immunotherapy. | Laskowski TJ et al. | β | 2022 | β |
| Nicotinamide Promotes Formation of Retinal Organoids From Human Pluripotent Stem Cells <i>via</i> Enhanced Neural Cell Fate Commitment. | Regent F et al. | β | 2022 | β |
| Oncogenes and the Origins of Leukemias. | Brown G | β | 2022 | β |
| Parthenolide and arsenic trioxide co-trigger autophagy-accompanied apoptosis in hepatocellular carcinoma cells. | Yi J et al. | β | 2022 | β |
| Passage number affects differentiation of sensory neurons from human induced pluripotent stem cells. | Cantor EL et al. | β | 2022 | β |
| Patient-Derived InΒ Vitro Models of Microglial Function and Synaptic Engulfment in Schizophrenia. | Sheridan SD et al. | β | 2022 | β |
| Plumping up a Cushion of Human Biowaste in Regenerative Medicine: Novel Insights into a State-of-the-Art Reserve Arsenal. | Najafi-Ghalehlou N et al. | β | 2022 | β |
| Protocol for the generation of human induced hepatic stem cells using Sendai virus vectors. | Noguchi H et al. | β | 2022 | β |
| Raman microspectroscopy reveals unsaturation heterogeneity at the lipid droplet level and validates an <i>in vitro</i> model of bone marrow adipocyte subtypes. | Tratwal J et al. | β | 2022 | β |
| Reprogramming cell fates towards novel cancer immunotherapies. | Leung EHW et al. | β | 2022 | β |
| Rock inhibitor may compromise human induced pluripotent stem cells for cardiac differentiation in 3D. | Jiang B et al. | β | 2022 | β |
| Role of epigenetics in cellular reprogramming; from iPSCs to disease modeling and cell therapy. | Li Y et al. | β | 2022 | β |
| Scalable manufacturing of clinical-grade differentiated cardiomyocytes derived from human-induced pluripotent stem cells for regenerative therapy. | Morita Y et al. | β | 2022 | β |
| Skeletal muscle differentiation of human iPSCs meets bioengineering strategies: perspectives and challenges. | Iberite F et al. | β | 2022 | β |
| Stargardt disease and progress in therapeutic strategies. | Huang D et al. | β | 2022 | β |
| The Efficiency of Direct Maturation: the Comparison of Two hiPSC Differentiation Approaches into Motor Neurons. | Schaefers C et al. | β | 2022 | β |
| The neurovascular unit in leukodystrophies: towards solving the puzzle. | Zarekiani P et al. | β | 2022 | β |
| Tumor reversion and embryo morphogenetic factors. | Proietti S et al. | β | 2022 | β |
| Using MS induced pluripotent stem cells to investigate MS aetiology. | Fortune AJ et al. | β | 2022 | β |
| 5-Aza-2'-Deoxycytidine and Valproic Acid in Combination with CHIR99021 and A83-01 Induce Pluripotency Genes Expression in Human Adult Somatic Cells. | Aguirre-VΓ‘zquez A et al. | β | 2021 | β |
| Accentuating the sources of mesenchymal stem cells as cellular therapy for osteoarthritis knees-a panoramic review. | Muthu S et al. | β | 2021 | β |
| A Concise Review on Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Personalized Regenerative Medicine. | Pushp P et al. | β | 2021 | β |
| Addressing Manufacturing Challenges for Commercialization of iPSC-Based Therapies. | Dashtban M et al. | β | 2021 | β |
| Age-Related Macular Degeneration: From Epigenetics to Therapeutic Implications. | Farkas MH et al. | β | 2021 | β |
| A New Induction Method for the Controlled Differentiation of Human-Induced Pluripotent Stem Cells Using Frozen Sections. | Tadokoro S et al. | β | 2021 | β |
| An implantable human stem cell-derived tissue-engineered rostral migratory stream for directed neuronal replacement. | O'Donnell JC et al. | β | 2021 | β |
| Application of hiPSCs in tooth regeneration via cellular modulation. | Mai HN et al. | β | 2021 | β |
| A review of diabetic wound models-Novel insights into diabetic foot ulcer. | Phang SJ et al. | β | 2021 | β |
| A ride through the epigenetic landscape: aging reversal by reprogramming. | de Lima Camillo LP et al. | β | 2021 | β |
| Artificially produced gametes in mice, humans and other species. | Hayashi K et al. | β | 2021 | β |
| Astrocytes and neurons share region-specific transcriptional signatures that confer regional identity to neuronal reprogramming. | Herrero-Navarro Γ et al. | β | 2021 | β |
| Cardiac Fibroblasts and Myocardial Regeneration. | Chen W et al. | β | 2021 | β |
| Cell division- and DNA replication-free reprogramming of somatic nuclei for embryonic transcription. | Tomikawa J et al. | β | 2021 | β |
| Cell Reprogramming to Model Huntington's Disease: A Comprehensive Review. | Monk R et al. | β | 2021 | β |
| Cell therapy and delivery strategies for spinal cord injury. | Ramalho BDS et al. | β | 2021 | β |
| Cerebral Organoids-Challenges to Establish a Brain Prototype. | Eremeev AV et al. | β | 2021 | β |
| Cis-acting: A pattern of lncRNAs for gene regulation in induced pluripotent stem cells from patients with Down syndrome determined by integrative analysis of lncRNA and mRNA profiling data. | Ma W et al. | β | 2021 | β |
| Contribution of Human Pluripotent Stem Cell-Based Models to Drug Discovery for Neurological Disorders. | Benchoua A et al. | β | 2021 | β |
| Correction of Heritable Epigenetic Defects Using Editing Tools. | Handal T et al. | β | 2021 | β |
| Current Perspectives on the Use of off the Shelf CAR-T/NK Cells for the Treatment of Cancer. | Cutmore LC et al. | β | 2021 | β |
| Current understanding of the molecular and cellular pathology of diabetic retinopathy. | Antonetti DA et al. | β | 2021 | β |
| Development, characterization, and hematopoietic differentiation of Griscelli syndrome type 2 induced pluripotent stem cells. | GΓΌney-Esken G et al. | β | 2021 | β |
| Embryonic Stem Cells in Clinical Trials: Current Overview of Developments and Challenges. | Golchin A et al. | β | 2021 | β |
| Emerging hiPSC Models for Drug Discovery in Neurodegenerative Diseases. | Trudler D et al. | β | 2021 | β |
| Emerging role of G9a in cancer stemness and promises as a therapeutic target. | Haebe JR et al. | β | 2021 | β |
| Epigenetic reprogramming of cell identity: lessons from development for regenerative medicine. | Basu A et al. | β | 2021 | β |
| GATA6 regulates aging of human mesenchymal stem/stromal cells. | Jiao H et al. | β | 2021 | β |
| Gene and protein expression in human megakaryocytes derived from induced pluripotent stem cells. | Kammers K et al. | β | 2021 | β |
| Gene Expression in Pancreatic Cancer-Like Cells and Induced Pancreatic Stem Cells Generated by Transient Overexpression of Reprogramming Factors. | Miyagi-Shiohira C et al. | β | 2021 | β |
| Generation of Induced Pluripotent Stem Cells from Patients with Multiple Myeloma | YΔ±lmaz BaΕaran Δ° et al. | β | 2021 | β |
| Great Expectations: Induced pluripotent stem cell technologies in neurodevelopmental impairments. | Zhang X et al. | β | 2021 | β |
| H3K4 di-methylation governs smooth muscle lineage identity and promotes vascular homeostasis by restraining plasticity. | Liu M et al. | β | 2021 | β |
| Highly Effective Protocol for Differentiation of Induced Pluripotent Stem Cells (iPS) into Melanin-Producing Cells. | SuΕkowski M et al. | β | 2021 | β |
| hiPSCs for predictive modelling of neurodegenerative diseases: dreaming the possible. | Rivetti di Val Cervo P et al. | β | 2021 | β |
| Human Induced Pluripotent Stem Cell as a Disease Modeling and Drug Development Platform-A Cardiac Perspective. | Bekhite MM et al. | β | 2021 | β |
| Human-induced pluripotent stem cells for modelling metabolic perturbations and impaired bioenergetics underlying cardiomyopathies. | Ramachandra CJA et al. | β | 2021 | β |
| Human stem cell-derived microglia will be an indispensable toolbox for Alzheimer's disease research. | Liu T | β | 2021 | β |
| Immunological considerations and challenges for regenerative cellular therapies. | Petrus-Reurer S et al. | β | 2021 | β |
| Induced pluripotency in the context of stem cell expansion bioprocess development, optimization, and manufacturing: a roadmap to the clinic. | Colter J et al. | β | 2021 | β |
| Induced Pluripotent Stem Cells as a Tool for Modeling Hematologic Disorders and as a Potential Source for Cell-Based Therapies. | Pratumkaew P et al. | β | 2021 | β |
| Induced pluripotent stem cells derived from the developing striatum as a potential donor source for cell replacement therapy for Huntington disease. | Choompoo N et al. | β | 2021 | β |
| Induced Pluripotent Stem Cells in Psychiatry: An Overview and Critical Perspective. | De Los Angeles A et al. | β | 2021 | β |
| Induced Pluripotent Stem Cells to Model Juvenile Myelomonocytic Leukemia: New Perspectives for Preclinical Research. | Wehbe Z et al. | β | 2021 | β |
| Induced pluripotent stem cell technology: trends in molecular biology, from genetics to epigenetics. | Maali A et al. | β | 2021 | β |
| Induced Tissue-Specific Stem Cells (iTSCs): Their Generation and Possible Use in Regenerative Medicine. | Saitoh I et al. | β | 2021 | β |
| Induction and Maturation of Hepatocyte-Like Cells <i>In Vitro</i>: Focus on Technological Advances and Challenges. | Xie Y et al. | β | 2021 | β |
| Industrially Compatible Transfusable iPSC-Derived RBCs: Progress, Challenges and Prospective Solutions. | Lim ZR et al. | β | 2021 | β |
| In Search of a Unifying Concept in Human Diseases. | Trosko JE | β | 2021 | β |
| iPSC diversity: A key for better use and improved targeting. | Abbonante V et al. | β | 2021 | β |
| iPSC Preparation and Epigenetic Memory: Does the Tissue Origin Matter? | Scesa G et al. | β | 2021 | β |
| Mesenchymal stromal cells in the bone marrow niche consist of multi-populations with distinct transcriptional and epigenetic properties. | Kanazawa S et al. | β | 2021 | β |
| Methods to produce induced pluripotent stem cell-derived mesenchymal stem cells: Mesenchymal stem cells from induced pluripotent stem cells. | Dupuis V et al. | β | 2021 | β |
| Microphysiological systems: What it takes for community adoption. | Hargrove-Grimes P et al. | β | 2021 | β |
| Modeling Cardiomyopathies in a Dish: State-of-the-Art and Novel Perspectives on hiPSC-Derived Cardiomyocytes Maturation. | Lodola F et al. | β | 2021 | β |
| Modeling Neurological Disorders in 3D Organoids Using Human-Derived Pluripotent Stem Cells. | Bose R et al. | β | 2021 | β |
| Novel Technique for Retinal Nerve Cell Regeneration with Electrophysiological Functions Using Human Iris-Derived iPS Cells. | Yamamoto N et al. | β | 2021 | β |
| Organs-on-chips: into the next decade. | Low LA et al. | β | 2021 | β |
| Oxygen as a Master Regulator of Human Pluripotent Stem Cell Function and Metabolism. | Nit K et al. | β | 2021 | β |
| Patient-specific iPSCs carrying an SFTPC mutation reveal the intrinsic alveolar epithelial dysfunction at the inception of interstitial lung disease. | Alysandratos KD et al. | β | 2021 | β |
| Precision Medicine and cardiac channelopathies: when dreams meet reality. | Gnecchi M et al. | β | 2021 | β |
| Primary neuron and astrocyte cultures from postnatal Callithrix jacchus: a non-human primate in vitro model for research in neuroscience, nervous system aging, and neurological diseases of aging. | Dorigatti AO et al. | β | 2021 | β |
| Prospects for Development of Induced Pluripotent Stem Cell-Derived CAR-Targeted Immunotherapies. | Mazza R et al. | β | 2021 | β |
| Regulatory Dendritic Cells, T Cell Tolerance, and Dendritic Cell Therapy for Immunologic Disease. | Ness S et al. | β | 2021 | β |
| Retinal Lineage Therapeutic Specific Effect of Human Orbital and Abdominal Adipose-Derived Mesenchymal Stem Cells. | Krief B et al. | β | 2021 | β |
| Retina stem cells, hopes and obstacles. | German OL et al. | β | 2021 | β |
| Rewinding Extinction in the Northern White Rhinoceros: Genetically Diverse Induced Pluripotent Stem Cell Bank for Genetic Rescue. | Korody ML et al. | β | 2021 | β |
| Somatic Reprogramming-Above and Beyond Pluripotency. | Meir YJ et al. | β | 2021 | β |
| Stem Cell Secretome for Spinal Cord Repair: Is It More than Just a Random Baseline Set of Factors? | Pajer K et al. | β | 2021 | β |
| Stem cell therapy in the heart: Biomaterials as a key route. | Hashemzadeh MR et al. | β | 2021 | β |
| Studying human nociceptors: from fundamentals to clinic. | Middleton SJ et al. | β | 2021 | β |
| T-Cell Dysfunction as a Limitation of Adoptive Immunotherapy: Current Concepts and Mitigation Strategies. | Janelle V et al. | β | 2021 | β |
| TDG is a pig-specific epigenetic regulator with insensitivity to H3K9 and H3K27 demethylation in nuclear transfer embryos. | Liu X et al. | β | 2021 | β |
| The Application of Induced Pluripotent Stem Cells Against Liver Diseases: An Update and a Review. | Zhang L et al. | β | 2021 | β |
| The difficulty to model Huntington's disease in vitro using striatal medium spiny neurons differentiated from human induced pluripotent stem cells. | Le Cann K et al. | β | 2021 | β |
| The Feasibility and Applicability of Stem Cell Therapy for the Cure of Type 1 Diabetes. | Inoue R et al. | β | 2021 | β |
| The Potential of Induced Pluripotent Stem Cells to Treat and Model Alzheimer's Disease. | Schulz JM | β | 2021 | β |
| Transcription Factor Reprogramming in the Inner Ear: Turning on Cell Fate Switches to Regenerate Sensory Hair Cells. | Iyer AA et al. | β | 2021 | β |
| Transient reprogramming of postnatal cardiomyocytes to a dedifferentiated state. | Kisby T et al. | β | 2021 | β |
| Transplantation of Human Cortically-Specified Neuroepithelial Progenitor Cells Leads to Improved Functional Outcomes in a Mouse Model of Stroke. | Islam R et al. | β | 2021 | β |
| Ubiquitous Chromatin Modifiers in Congenital Retinal Diseases: Implications for Disease Modeling and Regenerative Medicine. | Basinski BW et al. | β | 2021 | β |
| 16p11.2 microdeletion imparts transcriptional alterations in human iPSC-derived models of early neural development. | Roth JG et al. | β | 2020 | β |
| 3,2'-Dihydroxyflavone Improves the Proliferation and Survival of Human Pluripotent Stem Cells and Their Differentiation into Hematopoietic Progenitor Cells. | Kim K et al. | β | 2020 | β |
| A circular RNA map for human induced pluripotent stem cells of foetal origin. | Barilani M et al. | β | 2020 | β |
| Advances in Pluripotent Stem Cells: History, Mechanisms, Technologies, and Applications. | Liu G et al. | β | 2020 | β |
| Allogeneic human umbilical cord Wharton's jelly stem cells increase several-fold the expansion of human cord blood CD34+ cells both in vitro and in vivo. | Lin HD et al. | β | 2020 | β |
| Alveolar wars: The rise of in vitro models to understand human lung alveolar maintenance, regeneration, and disease. | Evans KV et al. | β | 2020 | β |
| A PIANO (Proper, Insufficient, Aberrant, and NO Reprogramming) Response to the Yamanaka Factors in the Initial Stages of Human iPSC Reprogramming. | Hu K | β | 2020 | β |
| Applications of Functional Genomics for Drug Discovery. | Kabadi A et al. | β | 2020 | β |
| "Betwixt Mine Eye and Heart a League Is Took": The Progress of Induced Pluripotent Stem-Cell-Based Models of Dystrophin-Associated Cardiomyopathy. | Rovina D et al. | β | 2020 | β |
| Cell-Based Therapy Manufacturing in Stirred Suspension Bioreactor: Thoughts for cGMP Compliance. | Nath SC et al. | β | 2020 | β |
| Cell therapy for type 1 diabetes. | Loretelli C et al. | β | 2020 | β |
| Chondrogenic Differentiation from Induced Pluripotent Stem Cells Using Non-Viral Minicircle Vectors. | Rim YA et al. | β | 2020 | β |
| Cystic renal-epithelial derived induced pluripotent stem cells from polycystic kidney disease patients. | Kenter AT et al. | β | 2020 | β |
| Decoding Parkinson's disease - iPSC-derived models in the OMICs era. | Krach F et al. | β | 2020 | β |
| Designing a blueprint for next-generation stem cell bioprocessing development. | Kim MH et al. | β | 2020 | β |
| Diabetes Mellitus Is a Chronic Disease that Can Benefit from Therapy with Induced Pluripotent Stem Cells. | Arroyave F et al. | β | 2020 | β |
| Differentiation of human induced pluripotent stem cells into erythroid cells. | Ebrahimi M et al. | β | 2020 | β |
| DNMT3B deficiency alters mitochondrial biogenesis and Ξ±-ketoglutarate levels in human embryonic stem cells. | Cieslar-Pobuda A et al. | β | 2020 | β |
| Double sperm cloning (DSC) is a promising strategy in mammalian genetic engineering and stem cell research. | Zhang ZP et al. | β | 2020 | β |
| Drug-Induced NaΓ―ve iPS Cells Exhibit Better Performance than Primed iPS Cells with Respect to the Ability to Differentiate into Pancreatic Ξ²-Cell Lineage. | Kiyokawa Y et al. | β | 2020 | β |
| Dysregulation of Neurite Outgrowth and Cell Migration in Autism and Other Neurodevelopmental Disorders. | Prem S et al. | β | 2020 | β |
| Energy Metabolism Regulates Stem Cell Pluripotency. | Tsogtbaatar E et al. | β | 2020 | β |
| Engineering Biomaterials with Micro/Nanotechnologies for Cell Reprogramming. | Fang J et al. | β | 2020 | β |
| Epigenetic memory in development and disease: Unraveling the mechanism. | Thiagalingam S | β | 2020 | β |
| Epigenetic Memory: Lessons From iPS Cells Derived From Human Ξ² Cells. | Efrat S | β | 2020 | β |
| Feeder-free generation and transcriptome characterization of functional mesenchymal stromal cells from human pluripotent stem cells. | Luo L et al. | β | 2020 | β |
| Generation of Human-Induced Pluripotent Stem Cells From Anterior Cruciate Ligament. | Woods S et al. | β | 2020 | β |
| Genome-wide R-loop Landscapes during Cell Differentiation and Reprogramming. | Yan P et al. | β | 2020 | β |
| High Frequency Production of T Cell-Derived iPSC Clones Capable of Generating Potent Cytotoxic T Cells. | Nagano S et al. | β | 2020 | β |
| Human Induced Pluripotent Stem Cell Models of Neurodegenerative Disorders for Studying the Biomedical Implications of Autophagy. | Seranova E et al. | β | 2020 | β |
| Human in vitro models for understanding mechanisms of autism spectrum disorder. | Gordon A et al. | β | 2020 | β |
| Human Pluripotent Stem Cells: Applications and Challenges for Regenerative Medicine and Disease Modeling. | Miranda CC et al. | β | 2020 | β |
| Human Pluripotent Stem Cells-Based Therapies for Neurodegenerative Diseases: Current Status and Challenges. | Ford E et al. | β | 2020 | β |
| Human sensory neurons derived from pluripotent stem cells for disease modelling and personalized medicine. | Lampert A et al. | β | 2020 | β |
| Human-stimulated oocyte extract induces genetic and mitochondrial reprogramming of mesenchymal stromal cells. | El-Gammal Z et al. | β | 2020 | β |
| Improved Isolation and Culture of Urine-Derived Stem Cells (USCs) and Enhanced Production of Immune Cells from the USC-Derived Induced Pluripotent Stem Cells. | Kim K et al. | β | 2020 | β |
| Induced Pluripotency: A Powerful Tool for In Vitro Modeling. | Zahumenska R et al. | β | 2020 | β |
| Induced Pluripotent Stem Cells in Dental and Nondental Tissue Regeneration: A Review of an Unexploited Potential. | Radwan IA et al. | β | 2020 | β |
| Induced pluripotent stem cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy. | Horton C et al. | β | 2020 | β |
| Induced pluripotent stem cells to model adverse drug reactions in pediatric patients. | Genova E et al. | β | 2020 | β |
| Insulin/Glucose-Responsive Cells Derived from Induced Pluripotent Stem Cells: Disease Modeling and Treatment of Diabetes. | Gheibi S et al. | β | 2020 | β |
| iPSC modeling of young-onset Parkinson's disease reveals a molecular signature of disease and novel therapeutic candidates. | Laperle AH et al. | β | 2020 | β |
| Kidney Organoids and Tubuloids. | Yousef Yengej FA et al. | β | 2020 | β |
| Manipulating the Mediator complex to induce naΓ―ve pluripotency. | Lynch CJ et al. | β | 2020 | β |
| Modeling and Targeting Alzheimer's Disease With Organoids. | Papaspyropoulos A et al. | β | 2020 | β |
| Modeling Psychiatric Disorder Biology with Stem Cells. | Das D et al. | β | 2020 | β |
| Multi-omic comparison of Alzheimer's variants in human ESC-derived microglia reveals convergence at APOE. | Liu T et al. | β | 2020 | β |
| Murine Mesenchymal Stromal Cells Retain Biased Differentiation Plasticity Towards Their Tissue of Origin. | Ng TT et al. | β | 2020 | β |
| New Application of Osteogenic Differentiation from HiPS Stem Cells for Evaluating the Osteogenic Potential of Nanomaterials in Dentistry. | TetΓ¨ G et al. | β | 2020 | β |
| Non-viral reprogramming and induced pluripotent stem cells for cardiovascular therapy. | Panda A et al. | β | 2020 | β |
| Novel therapeutic strategies for Alzheimer's disease: Implications from cell-based therapy and nanotherapy. | Derakhshankhah H et al. | β | 2020 | β |
| Origin of the Induced Pluripotent Stem Cells Affects Their Differentiation into Dopaminergic Neurons. | Chlebanowska P et al. | β | 2020 | β |
| Pluripotent-Stem-Cell-Derived Hepatic Cells: Hepatocytes and Organoids for Liver Therapy and Regeneration. | Messina A et al. | β | 2020 | β |
| Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Show Comparable Functionality to Their Autologous Origin. | Jakob M et al. | β | 2020 | β |
| Pluripotent stem cells with low differentiation potential contain incompletely reprogrammed DNA replication. | Paniza T et al. | β | 2020 | β |
| Prime time for primate functional genomics. | Housman G et al. | β | 2020 | β |
| Protocol to Reprogram Human Menstrual Blood-Derived Stromal Cells to Generate AOX15-iPSCs. | Sanzhez-Mata A et al. | β | 2020 | β |
| Recent progress in translational engineered in vitro models of the central nervous system. | Nikolakopoulou P et al. | β | 2020 | β |
| Regeneration of Tumor-Antigen-Specific Cytotoxic T Lymphocytes from iPSCs Transduced with Exogenous TCR Genes. | Maeda T et al. | β | 2020 | β |
| "Reprogram Enablement" as an Assay for Identifying Early Oncogenic Pathways by Their Ability to Allow Neoplastic Cells to Reacquire an Epiblast State. | Kong Y et al. | β | 2020 | β |
| Reprogrammed astrocytes display higher neurogenic competence, migration ability and cell death resistance than reprogrammed fibroblasts. | Xia X et al. | β | 2020 | β |
| Resistance of KIR Ligand-Missing Leukocytes to NK Cells In Vivo in Patients with Acquired Aplastic Anemia. | Nguyen MAT et al. | β | 2020 | β |
| Resolving Neurodevelopmental and Vision Disorders Using Organoid Single-Cell Multi-omics. | Brancati G et al. | β | 2020 | β |
| Retention of Somatic Memory Associated with Cell Identity, Age and Metabolism in Induced Pluripotent Stem (iPS) Cells Reprogramming. | Khoo TS et al. | β | 2020 | β |
| Specification of the First Mammalian Cell Lineages In Vivo and In Vitro. | White MD et al. | β | 2020 | β |
| Stem Cells for Improving the Treatment of Neurodevelopmental Disorders. | Donegan JJ et al. | β | 2020 | β |
| Stem cell therapy: old challenges and new solutions. | Balistreri CR et al. | β | 2020 | β |
| Switching of vascular cells towards atherogenesis, and other factors contributing to atherosclerosis: a systematic review. | Shafi O | β | 2020 | β |
| Targeting cell plasticity for regeneration: From in vitro to in vivo reprogramming. | Romanazzo S et al. | β | 2020 | β |
| The application of human pluripotent stem cells to model the neuronal and glial components of neurodevelopmental disorders. | Lee KM et al. | β | 2020 | β |
| The combination of dibenzazepine and a DOT1L inhibitor enables a stable maintenance of human naΓ―ve-state pluripotency in non-hypoxic conditions. | Isono W et al. | β | 2020 | β |
| The Emerging Role of Stem Cells in Regenerative Dentistry. | CapparΓ¨ P et al. | β | 2020 | β |
| The FGF, TGFΞ² and WNT axis Modulate Self-renewal of Human SIX2<sup>+</sup> Urine Derived Renal Progenitor Cells. | Rahman MS et al. | β | 2020 | β |
| The Master Regulator Protein BAZ2B Can Reprogram Human Hematopoietic Lineage-Committed Progenitors into a Multipotent State. | Arumugam K et al. | β | 2020 | β |
| The Molecular Mechanisms of Adaptive Response Related to Environmental Stress. | Rossnerova A et al. | β | 2020 | β |
| The Use of Induced Pluripotent Stem Cells as a Model for Developmental Eye Disorders. | Eintracht J et al. | β | 2020 | β |
| Toward a better definition of hematopoietic progenitors suitable for B cell differentiation. | Dubois F et al. | β | 2020 | β |
| Transcriptional memory inherited from donor cells is a developmental defect of bovine cloned embryos. | Zhou C et al. | β | 2020 | β |
| Transcriptome Analyses Reveal Differential Transcriptional Profiles in Early- and Late-Dividing Porcine Somatic Cell Nuclear Transfer Embryos. | Liu Z et al. | β | 2020 | β |
| Umbilical Cord Tissue as a Source of Young Cells for the Derivation of Induced Pluripotent Stem Cells Using Non-Integrating Episomal Vectors and Feeder-Free Conditions. | Mohamed A et al. | β | 2020 | β |
| Variable Outcomes in Neural Differentiation of Human PSCs Arise from Intrinsic Differences in Developmental Signaling Pathways. | Strano A et al. | β | 2020 | β |
| Versatility of Induced Pluripotent Stem Cells (iPSCs) for Improving the Knowledge on Musculoskeletal Diseases. | Sanjurjo-RodrΓguez C et al. | β | 2020 | β |
| Vibrational Spectroscopy for In Vitro Monitoring Stem Cell Differentiation. | Ravera F et al. | β | 2020 | β |
| Allele-specific RNA-seq expression profiling of imprinted genes in mouse isogenic pluripotent states. | Dirks RAM et al. | β | 2019 | β |
| An iPSC-Derived Myeloid Lineage Model of Herpes Virus Latency and Reactivation. | Poole E et al. | β | 2019 | β |
| Application of Urine-Derived Stem Cells to Cellular Modeling in Neuromuscular and Neurodegenerative Diseases. | Sato M et al. | β | 2019 | β |
| Are There Common Mechanisms Between the Hutchinson-Gilford Progeria Syndrome and Natural Aging? | Ashapkin VV et al. | β | 2019 | β |
| Bone tissue regeneration: biology, strategies and interface studies. | Ansari M | β | 2019 | β |
| Cardiac Progenitor Cells from Stem Cells: Learning from Genetics and Biomaterials. | Barreto S et al. | β | 2019 | β |
| Comprehensive proteogenomic analysis of human embryonic and induced pluripotent stem cells. | Parrotta EI et al. | β | 2019 | β |
| Concise Review: The Current State of Human In Vitro Cardiac Disease Modeling: A Focus on Gene Editing and Tissue Engineering. | Hoes MF et al. | β | 2019 | β |
| Concise Review: Towards the Clinical Translation of Induced Pluripotent Stem Cell-Derived Blood Cells-Ready for Take-Off. | Haake K et al. | β | 2019 | β |
| Cost-Effective Cosmetic-Grade Hyaluronan Hydrogels for ReNcell VM Human Neural Stem Cell Culture. | Ma W et al. | β | 2019 | β |
| Current Challenges of iPSC-Based Disease Modeling and Therapeutic Implications. | Doss MX et al. | β | 2019 | β |
| CXCL4/PF4 is a predictive biomarker of cardiac differentiation potential of human induced pluripotent stem cells. | Ohashi F et al. | β | 2019 | β |
| Dedifferentiation, transdifferentiation and cell fusion: inΒ vivo reprogramming strategies for regenerative medicine. | Pesaresi M et al. | β | 2019 | β |
| DeepNEU: cellular reprogramming comes of age - a machine learning platform with application to rare diseases research. | Danter WR | β | 2019 | β |
| Demethylation around the transcriptional start site of the IFN-Ξ² gene induces IFN-Ξ² production and protection against influenza virus infection. | Nishioka K et al. | β | 2019 | β |
| Development of innate immune cells from human pluripotent stem cells. | Bernareggi D et al. | β | 2019 | β |
| Differential regulation of OCT4 targets facilitates reacquisition of pluripotency. | Thakurela S et al. | β | 2019 | β |
| Dysfunction telomeres in embryonic fibroblasts and cultured <i>in vitro</i> pluripotent stem cells of <i>Rattus norvegicus</i> (Rodentia, Muridae). | Zhdanova NS et al. | β | 2019 | β |
| Early onset preeclampsia in a model for human placental trophoblast. | Sheridan MA et al. | β | 2019 | β |
| Elimination of human folypolyglutamate synthetase alters programming and plasticity of somatic cells. | Srivastava AC et al. | β | 2019 | β |
| Environmental exposures, stem cells, and cancer. | Thong T et al. | β | 2019 | β |
| Epigenetic aberrations in human pluripotent stem cells. | Bar S et al. | β | 2019 | β |
| Evolving principles underlying neural lineage conversion and their relevance for biomedical translation. | Flitsch LJ et al. | β | 2019 | β |
| Extensive Recovery of Embryonic Enhancer and Gene Memory Stored in Hypomethylated Enhancer DNA. | Jadhav U et al. | β | 2019 | β |
| Generation and miRNA Characterization of Equine Induced Pluripotent Stem Cells Derived from Fetal and Adult Multipotent Tissues. | PessΓ΄a LVF et al. | β | 2019 | β |
| Glycolytic Switch Is Required for Transdifferentiation to Endothelial Lineage. | Lai L et al. | β | 2019 | β |
| Haematopoietic stem cell reprogramming and the hope for a universal blood product. | Barcia DurΓ‘n JG et al. | β | 2019 | β |
| Harnessing targeted DNA methylation and demethylation using dCas9. | Pflueger C et al. | β | 2019 | β |
| How Does Reprogramming to Pluripotency Affect Genomic Imprinting? | Perrera V et al. | β | 2019 | β |
| Human amniotic fluid stem cells (hAFSCs) expressing p21 and cyclin D1 genes retain excellent viability after freezing with (dimethyl sulfoxide) DMSO. | Gholizadeh-Ghaleh Aziz S et al. | β | 2019 | β |
| Human iPSC banking: barriers and opportunities. | Huang CY et al. | β | 2019 | β |
| Immunomodulatory effects of interferon-Ξ³ on human fetal cardiac mesenchymal stromal cells. | Grinnemo KH et al. | β | 2019 | β |
| Increased Neuronal Differentiation Efficiency in High Cell Density-Derived Induced Pluripotent Stem Cells. | Srimasorn S et al. | β | 2019 | β |
| Induced Pluripotent Stem Cell (iPSC)-Derived Lymphocytes for Adoptive Cell Immunotherapy: Recent Advances and Challenges. | Nianias A et al. | β | 2019 | β |
| Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development. | Karagiannis P et al. | β | 2019 | β |
| Induced pluripotent stem cells: A new strategy to model human cancer. | Bindhya S et al. | β | 2019 | β |
| Induced pluripotent stem cells for therapy personalization in pediatric patients: Focus on drug-induced adverse events. | Genova E et al. | β | 2019 | β |
| Induced Pluripotent Stem Cells (iPSCs) in Developmental Toxicology. | Easley CA | β | 2019 | β |
| Induced Pluripotent Stem Cells Reprogrammed with Three Inhibitors Show Accelerated Differentiation Potentials with High Levels of 2-Cell Stage Marker Expression. | Nishihara K et al. | β | 2019 | β |
| Induction of Expandable Tissue-Specific Progenitor Cells from Human Pancreatic Tissue through Transient Expression of Defined Factors. | Noguchi H et al. | β | 2019 | β |
| Inhibition of Glioma Development by ASCL1-Mediated Direct Neuronal Reprogramming. | Cheng X et al. | β | 2019 | β |
| Insights into the biology of fibrodysplasia ossificans progressiva using patient-derived induced pluripotent stem cells. | Nakajima T et al. | β | 2019 | β |
| iPS-Cell Technology and the Problem of Genetic Instability-Can It Ever Be Safe for Clinical Use? | Attwood SW et al. | β | 2019 | β |
| Melatonin modifies SOX2<sup>+</sup> cell proliferation in dentate gyrus and modulates SIRT1 and MECP2 in long-term sleep deprivation. | Hinojosa-Godinez A et al. | β | 2019 | β |
| Metabolism Is a Key Regulator of Induced Pluripotent Stem Cell Reprogramming. | Spyrou J et al. | β | 2019 | β |
| Metabolomic and Transcriptional Analyses Reveal Atmospheric Oxygen During Human Induced Pluripotent Stem Cell Generation Impairs Metabolic Reprogramming. | Spyrou J et al. | β | 2019 | β |
| Modeling Disease with Human Inducible Pluripotent Stem Cells. | Grandy R et al. | β | 2019 | β |
| Modeling of Fibrotic Lung Disease Using 3D Organoids Derived from Human Pluripotent Stem Cells. | Strikoudis A et al. | β | 2019 | β |
| Modeling Psychiatric Diseases with Induced Pluripotent Stem Cells. | van Hugte E et al. | β | 2019 | β |
| Multilayer Capsules Inside Biological Systems: State-of-the-Art and Open Challenges. | Zyuzin MV et al. | β | 2019 | β |
| Pluripotent Stem Cell Heterogeneity. | Hayashi Y et al. | β | 2019 | β |
| Rational Reprogramming of Cellular States by Combinatorial Perturbation. | Duan J et al. | β | 2019 | β |
| Recent Advances of Useful Cell Sources in the Periodontal Regeneration. | Cho YD et al. | β | 2019 | β |
| Regulation of Genomic Output and (Pluri)potency in Regeneration. | Duncan EM et al. | β | 2019 | β |
| Regulation of the tenogenic gene expression in equine tenocyte-derived induced pluripotent stem cells by mechanical loading and Mohawk. | Yang F et al. | β | 2019 | β |
| Reprogramming: identifying the mechanisms that safeguard cell identity. | Brumbaugh J et al. | β | 2019 | β |
| Reprogramming of Urine-Derived Renal Epithelial Cells into iPSCs Using srRNA and Consecutive Differentiation into Beating Cardiomyocytes. | Steinle H et al. | β | 2019 | β |
| Reprogramming the Epigenome With Vitamin C. | Lee Chong T et al. | β | 2019 | β |
| Reversibility of irreversible aging. | Galkin F et al. | β | 2019 | β |
| Role of ten-eleven translocation proteins and 5-hydroxymethylcytosine in hepatocellular carcinoma. | Wang P et al. | β | 2019 | β |
| Somatic cell reprogramming as a tool for neurodegenerative diseases. | Ebrahimi A et al. | β | 2019 | β |
| Stem Cells in Cardiovascular Medicine: Historical Overview and Future Prospects. | Samak M et al. | β | 2019 | β |
| Strategies for derivation of endothelial lineages from human stem cells. | Xu M et al. | β | 2019 | β |
| Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models. | Logan S et al. | β | 2019 | β |
| Systematic Review on Therapeutic Strategies to Minimize Corneal Stromal Scarring After Injury. | Kwok SS et al. | β | 2019 | β |
| Transgenerational Inheritance of Environmentally Induced Epigenetic Alterations during Mammalian Development. | Legoff L et al. | β | 2019 | β |
| Various nuclear reprogramming systems using egg and oocyte materials. | Miyamoto K | β | 2019 | β |
| What Can Chemical Carcinogenesis Shed Light on the LNT Hypothesis in Radiation Carcinogenesis? | Trosko JE | β | 2019 | β |
| 3D Culture Method for Alzheimer's Disease Modeling Reveals Interleukin-4 Rescues AΞ²42-Induced Loss of Human Neural Stem Cell Plasticity. | Papadimitriou C et al. | β | 2018 | β |
| Advances in Drug Discovery and Development in Geriatric Psychiatry. | C Conley A et al. | β | 2018 | β |
| Age Is Relative-Impact of Donor Age on Induced Pluripotent Stem Cell-Derived Cell Functionality. | StrΓ€ssler ET et al. | β | 2018 | β |
| Age-Related Epigenetic Derangement upon Reprogramming and Differentiation of Cells from the Elderly. | Ravaioli F et al. | β | 2018 | β |
| A new perspective on lipid research in age-related macular degeneration. | van Leeuwen EM et al. | β | 2018 | β |
| A Summary of the Biological Processes, Disease-Associated Changes, and Clinical Applications of DNA Methylation. | Andersen GB et al. | β | 2018 | β |
| Augmentation of musculoskeletal regeneration: role for pluripotent stem cells. | Jevons LA et al. | β | 2018 | β |
| Automated Cell Culture Systems and Their Applications to Human Pluripotent Stem Cell Studies. | Daniszewski M et al. | β | 2018 | β |
| Bioinformatics analysis to screen key genes implicated in the differentiation of induced pluripotent stem cells to hepatocytes. | Lin R et al. | β | 2018 | β |
| Bladder regeneration through stem cell therapy. | Smolar J et al. | β | 2018 | β |
| Building Blood Vessels with Vascular Progenitor Cells. | Colunga T et al. | β | 2018 | β |
| Can We Engineer a Human Cardiac Patch for Therapy? | Zhang J et al. | β | 2018 | β |
| Cell Transplantation for Spinal Cord Injury: Tumorigenicity of Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cells. | Deng J et al. | β | 2018 | β |
| Cellular Models: HD Patient-Derived Pluripotent Stem Cells. | Geater C et al. | β | 2018 | β |
| Cellular reprogramming: A new way to understand aging mechanisms. | Yener Ilce B et al. | β | 2018 | β |
| Characterization of companion animal pluripotent stem cells. | Paterson YZ et al. | β | 2018 | β |
| Characterization of induced tissue-specific stem cells from pancreas by a synthetic self-replicative RNA. | Miyagi-Shiohira C et al. | β | 2018 | β |
| Combined RNA-seq and RAT-seq mapping of long noncoding RNAs in pluripotent reprogramming. | Du Z et al. | β | 2018 | β |
| Comparative study of periodontal differentiation propensity of induced pluripotent stem cells from different tissue origins. | Li J et al. | β | 2018 | β |
| Concise Review: Molecular Cytogenetics and Quality Control: Clinical Guardians for Pluripotent Stem Cells. | Rohani L et al. | β | 2018 | β |
| Corneal cell therapy: with iPSCs, it is no more a far-sight. | Chakrabarty K et al. | β | 2018 | β |
| Crosstalk between TGF-Ξ² signaling and epigenome. | Bai J et al. | β | 2018 | β |
| Dad's Snoring May Have Left Molecular Scars in Your DNA: the Emerging Role of Epigenetics in Sleep Disorders. | Morales-Lara D et al. | β | 2018 | β |
| Delivery systems of current biologicals for the treatment of chronic cutaneous wounds and severe burns. | Xue M et al. | β | 2018 | β |
| Different Chondrogenic Potential among Human Induced Pluripotent Stem Cells from Diverse Origin Primary Cells. | Rim YA et al. | β | 2018 | β |
| Differentiation of Mesenchymal Stem Cells from Human Induced Pluripotent Stem Cells Results in Downregulation of c-Myc and DNA Replication Pathways with Immunomodulation Toward CD4 and CD8 Cells. | Wang LT et al. | β | 2018 | β |
| Direct Control of Stem Cell Behavior Using Biomaterials and Genetic Factors. | Yoon JK et al. | β | 2018 | β |
| Direct Generation of Human Cortical Organoids from Primary Cells. | Schukking M et al. | β | 2018 | β |
| Directing neuronal cell fate in vitro: Achievements and challenges. | Riemens RJM et al. | β | 2018 | β |
| Drug screening for human genetic diseases using iPSC models. | Elitt MS et al. | β | 2018 | β |
| Dynamics of DNA Methylation Reprogramming Influenced by X Chromosome Dosage in Induced Pluripotent Stem Cells. | Janiszewski A et al. | β | 2018 | β |
| Editing the Epigenome: Reshaping the Genomic Landscape. | Holtzman L et al. | β | 2018 | β |
| Effect of prolonged differentiation on functional maturation of human pluripotent stem cell-derived neuronal cultures. | Paavilainen T et al. | β | 2018 | β |
| Epigenetic Approaches to the Treatment of Dental Pulp Inflammation and Repair: Opportunities and Obstacles. | Kearney M et al. | β | 2018 | β |
| Epigenetic control of gene regulation during development and disease: A view from the retina. | Corso-DΓaz X et al. | β | 2018 | β |
| Epigenetic differences between naΓ―ve and primed pluripotent stem cells. | Takahashi S et al. | β | 2018 | β |
| Epigenetic Enzymes, Age, and Ancestry Regulate the Efficiency of Human iPSC Reprogramming. | Mackey LC et al. | β | 2018 | β |
| Establishment of stable iPS-derived human neural stem cell lines suitable for cell therapies. | Rosati J et al. | β | 2018 | β |
| Feasibility of Induced Pluripotent Stem Cell Therapies for Treatment of Type 1 Diabetes. | Duffy C et al. | β | 2018 | β |
| From Genotype to Phenotype: A Primer on the Functional Follow-up of Genome-Wide Association Studies in Cardiovascular Disease. | Lin J et al. | β | 2018 | β |
| Gene expression changes in human iPSC-derived cardiomyocytes after X-ray irradiation. | Becker BV et al. | β | 2018 | β |
| Generation of human-induced pluripotent stem cells from burn patient-derived skin fibroblasts using a non-integrative method. | Fu S et al. | β | 2018 | β |
| Genetics of Alcohol Use Disorder: A Role for Induced Pluripotent Stem Cells? | Prytkova I et al. | β | 2018 | β |
| Genome-wide DNA methylation analysis reveals that mouse chemical iPSCs have closer epigenetic features to mESCs than OSKM-integrated iPSCs. | Ping W et al. | β | 2018 | β |
| Hematopoietic stem cells from induced pluripotent stem cells - considering the role of microRNA as a cell differentiation regulator. | Ferreira AF et al. | β | 2018 | β |
| Histone 3 lysine 4, 9, and 27 demethylases expression profile in fertilized and cloned bovine and porcine embryos. | Glanzner WG et al. | β | 2018 | β |
| How to build a lung: latest advances and emerging themes in lung bioengineering. | De Santis MM et al. | β | 2018 | β |
| Human stem cell modeling in neurofibromatosis type 1 (NF1). | Wegscheid ML et al. | β | 2018 | β |
| Impact of Ionizing Radiation on Electrophysiological Behavior of Human-induced Ipsc-derived Cardiomyocytes on Multielectrode Arrays. | Becker BV et al. | β | 2018 | β |
| Implications of Cellular Aging in Cardiac Reprogramming. | Passaro F et al. | β | 2018 | β |
| Induced pluripotent stem cells derived from human amnion in chemically defined conditions. | Slamecka J et al. | β | 2018 | β |
| Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling and Precision Medicine: A Scientific Statement From the American Heart Association. | Musunuru K et al. | β | 2018 | β |
| Induced Pluripotent Stem Cells to Study Mechanisms of Laminopathies: Focus on Epigenetics. | Crasto S et al. | β | 2018 | β |
| Induced Tissue-Specific Stem Cells and Epigenetic Memory in Induced Pluripotent Stem Cells. | Noguchi H et al. | β | 2018 | β |
| Induction of Expandable Adipose-Derived Mesenchymal Stem Cells from Aged Mesenchymal Stem Cells by a Synthetic Self-Replicating RNA. | Miyagi-Shiohira C et al. | β | 2018 | β |
| Intra-cavity stem cell therapy inhibits tumor progression in a novel murine model of medulloblastoma surgical resection. | Okolie O et al. | β | 2018 | β |
| Liver 'organ on a chip'. | Beckwitt CH et al. | β | 2018 | β |
| Lower genomic stability of induced pluripotent stem cells reflects increased non-homologous end joining. | Zhang M et al. | β | 2018 | β |
| Low Osteogenic Yield in Human Pluripotent Stem Cells Associates with Differential Neural Crest Promoter Methylation. | Sparks NRL et al. | β | 2018 | β |
| Metabolic profile and differentiation potential of extraembryonic endoderm-like cells. | Gatie MI et al. | β | 2018 | β |
| Modeling neurological diseases using iPSC-derived neural cells : iPSC modeling of neurological diseases. | Li L et al. | β | 2018 | β |
| Modeling rare diseases with induced pluripotent stem cell technology. | Anderson RH et al. | β | 2018 | β |
| Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent. | Fujimori K et al. | β | 2018 | β |
| Modulation of cardiac stem cell characteristics by metoprolol in hypertensive heart disease. | Saheera S et al. | β | 2018 | β |
| Nascent Induced Pluripotent Stem Cells Efficiently Generate Entirely iPSC-Derived Mice while Expressing Differentiation-Associated Genes. | Amlani B et al. | β | 2018 | β |
| Oral Mucosa-Derived Induced Pluripotent Stem Cells from Patients with Ectrodactyly-Ectodermal Dysplasia-Clefting Syndrome. | Trevisan M et al. | β | 2018 | β |
| Organs-on-a-Chip: A Fast Track for Engineered Human Tissues in Drug Development. | Ronaldson-Bouchard K et al. | β | 2018 | β |
| Pericytes Derived from Human Pluripotent Stem Cells. | Jamieson J et al. | β | 2018 | β |
| Physiological oxygen culture reveals retention of metabolic memory in human induced pluripotent stem cells. | Harvey AJ et al. | β | 2018 | β |
| Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects. | Sonntag KC et al. | β | 2018 | β |
| Pluripotent stem cells: induction and self-renewal. | Abu-Dawud R et al. | β | 2018 | β |
| Precise immune tolerance for hPSC derivatives in clinical application. | Zhu W et al. | β | 2018 | β |
| Preparation of Induced Pluripotent Stem Cells Using Human Peripheral Blood Monocytes. | Isogai S et al. | β | 2018 | β |
| Recent advances in stem cells therapy: A focus on cancer, Parkinson's and Alzheimer's. | Fleifel D et al. | β | 2018 | β |
| Regenerating the kidney using human pluripotent stem cells and renal progenitors. | Becherucci F et al. | β | 2018 | β |
| Report of the Key Opinion Leaders Meeting on Stem Cell-derived Beta Cells. | Odorico J et al. | β | 2018 | β |
| Reprogramming mechanisms influence the maturation of hematopoietic progenitors from human pluripotent stem cells. | Heo HR et al. | β | 2018 | β |
| Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor. | Tan YT et al. | β | 2018 | β |
| Retinal Cell Type DNA Methylation and Histone Modifications Predict Reprogramming Efficiency and Retinogenesis in 3D Organoid Cultures. | Wang L et al. | β | 2018 | β |
| Reverse engineering of triple-negative breast cancer cells for targeted treatment. | Bluemel L et al. | β | 2018 | β |
| Role of Egr1 on Pancreatic Endoderm Differentiation. | Tsugata T et al. | β | 2018 | β |
| Rules governing the mechanism of epigenetic reprogramming memory. | Luu PL et al. | β | 2018 | β |
| Single-cell RNA sequencing reveals metallothionein heterogeneity during hESC differentiation to definitive endoderm. | Lu J et al. | β | 2018 | β |
| Stem cell contributions to neurological disease modeling and personalized medicine. | Liang N et al. | β | 2018 | β |
| Studying non-alcoholic fatty liver disease: the ins and outs of in vivo, ex vivo and in vitro human models. | Green CJ et al. | β | 2018 | β |
| Synthetic transcription factors for cell fate reprogramming. | Black JB et al. | β | 2018 | β |
| Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications. | Omole AE et al. | β | 2018 | β |
| The Development of Cancer through the Transient Overexpression of Reprogramming Factors. | Miyagi-Shiohira C et al. | β | 2018 | β |
| The development of induced pluripotent stem cell-derived mesenchymal stem/stromal cells from normal human and RDEB epidermal keratinocytes. | Nakayama C et al. | β | 2018 | β |
| The effect of age on stem cell function and utility for therapy. | Narbonne P | β | 2018 | β |
| The Generation of Human Ξ³Ξ΄T Cell-Derived Induced Pluripotent Stem Cells from Whole Peripheral Blood Mononuclear Cell Culture. | Watanabe D et al. | β | 2018 | β |
| The impact of growth factors on human induced pluripotent stem cells differentiation into cardiomyocytes. | Yassa ME et al. | β | 2018 | β |
| The impact of in vitro cell culture duration on the maturation of human cardiomyocytes derived from induced pluripotent stem cells of myogenic origin. | Lewandowski J et al. | β | 2018 | β |
| The influence of rAAV2-mediated SOX2 delivery into neonatal and adult human RPE cells; a comparative study. | Ezati R et al. | β | 2018 | β |
| The limited application of stem cells in medicine: a review. | Poulos J | β | 2018 | β |
| The march of pluripotent stem cells in cardiovascular regenerative medicine. | Abou-Saleh H et al. | β | 2018 | β |
| The paracrine effects of human induced pluripotent stem cells promote bone-like structures via the upregulation of BMP expression in a mouse ectopic model. | Oudina K et al. | β | 2018 | β |
| The potential of human induced pluripotent stem cells for modelling diabetic wound healing <i>in vitro</i>. | Martin PE et al. | β | 2018 | β |
| The Role of the Mitochondria in the Evolution of Stem Cells, Including MUSE Stem Cells and Their Biology. | Trosko JE | β | 2018 | β |
| The role of the reprogramming method and pluripotency state in gamete differentiation from patient-specific human pluripotent stem cells. | Mishra S et al. | β | 2018 | β |
| The state of the art in stem cell biology and regenerative medicine: the end of the beginning. | Snyder EY | β | 2018 | β |
| The Telomerase Complex Directly Controls Hematopoietic Stem Cell Differentiation and Senescence in an Induced Pluripotent Stem Cell Model of Telomeropathy. | Jose SS et al. | β | 2018 | β |
| Tracing human stem cell lineage during development using DNA methylation. | Salas LA et al. | β | 2018 | β |
| Transcriptional landscape of a RET<sup>C634Y</sup>-mutated iPSC and its CRISPR-corrected isogenic control reveals the putative role of EGR1 transcriptional program in the development of multiple endocrine neoplasia type 2A-associated cancers. | Hadoux J et al. | β | 2018 | β |
| Transcriptome level analysis in Rett syndrome using human samples from different tissues. | Shovlin S et al. | β | 2018 | β |
| Aberrant DNA Methylation in Human iPSCs Associates with MYC-Binding Motifs in a Clone-Specific Manner Independent of Genetics. | Panopoulos AD et al. | β | 2017 | β |
| Alternative dominance of the parental genomes in hybrid cells generated through the fusion of mouse embryonic stem cells with fibroblasts. | Matveeva NM et al. | β | 2017 | β |
| Amniotic fluid stem cell models: A tool for filling the gaps in knowledge for human genetic diseases. | Antonucci I et al. | β | 2017 | β |
| Analysis of Transcriptional Variability in a Large Human iPSC Library Reveals Genetic and Non-genetic Determinants of Heterogeneity. | Carcamo-Orive I et al. | β | 2017 | β |
| Application of Stem Cells in Oral Disease Therapy: Progresses and Perspectives. | Yang B et al. | β | 2017 | β |
| Applications of Tissue Engineering in Joint Arthroplasty: Current Concepts Update. | Zeineddine HA et al. | β | 2017 | β |
| Are reprogrammed cells a useful tool for studying dopamine dysfunction in psychotic disorders? A review of the current evidence. | Sauerzopf U et al. | β | 2017 | β |
| A Singular Role of I<sub>K1</sub> Promoting the Development of Cardiac Automaticity during Cardiomyocyte Differentiation by I<sub>K1</sub> -Induced Activation of Pacemaker Current. | Sun Y et al. | β | 2017 | β |
| A systematic approach to cancer: evolution beyond selection. | Miller WB et al. | β | 2017 | β |
| Biological Significance of the Suppression of Oxidative Phosphorylation in Induced Pluripotent Stem Cells. | Zhang C et al. | β | 2017 | β |
| Biomarker Discovery by Modeling BehΓ§et's Disease with Patient-Specific Human Induced Pluripotent Stem Cells. | Son MY et al. | β | 2017 | β |
| Capturing Human NaΓ―ve Pluripotency in the Embryo and in the Dish. | Zimmerlin L et al. | β | 2017 | β |
| Cell-based therapeutic strategies for replacement and preservation in retinal degenerative diseases. | Jones MK et al. | β | 2017 | β |
| Cell Therapy for Type 1 Diabetes: Current and Future Strategies. | Aghazadeh Y et al. | β | 2017 | β |
| Cellular reprogramming for clinical cartilage repair. | Driessen BJH et al. | β | 2017 | β |
| Characterization and comparison of osteoblasts derived from mouse embryonic stem cells and induced pluripotent stem cells. | Ma MS et al. | β | 2017 | β |
| Combining membrane proteomics and computational three-way pathway analysis revealed signalling pathways preferentially regulated in human iPSCs and human ESCs. | Tien WS et al. | β | 2017 | β |
| Common genetic variation drives molecular heterogeneity in human iPSCs. | Kilpinen H et al. | β | 2017 | β |
| Concise Review: Embryonic Stem Cells Derived by Somatic Cell Nuclear Transfer: A Horse in the Race? | Wolf DP et al. | β | 2017 | β |
| Concise Review: Induced Pluripotent Stem Cell Models for Neuropsychiatric Diseases. | Adegbola A et al. | β | 2017 | β |
| Control of dental-derived induced pluripotent stem cells through modified surfaces for dental application. | Choi H et al. | β | 2017 | β |
| Coordinated generation of multiple ocular-like cell lineages and fabrication of functional corneal epithelial cell sheets from human iPS cells. | Hayashi R et al. | β | 2017 | β |
| Current and Future Perspectives of Stem Cell Therapy in Dermatology. | Prodinger CM et al. | β | 2017 | β |
| Current status in cancer cell reprogramming and its clinical implications. | Izgi K et al. | β | 2017 | β |
| Dental pulp stem cells for the study of neurogenetic disorders. | Victor AK et al. | β | 2017 | β |
| Derivation of Human Induced Pluripotent Stem Cell (iPSC) Lines and Mechanism of Pluripotency: Historical Perspective and Recent Advances. | Chhabra A | β | 2017 | β |
| Deriving Osteogenic Cells from Induced Pluripotent Stem Cells for Bone Tissue Engineering. | Wu Q et al. | β | 2017 | β |
| Differentiation and Application of Induced Pluripotent Stem Cell-Derived Vascular Smooth Muscle Cells. | Maguire EM et al. | β | 2017 | β |
| Directed Differentiation of Human Induced Pluripotent Stem Cells into Dendritic Cells Displaying Tolerogenic Properties and Resembling the CD141<sup>+</sup> Subset. | Sachamitr P et al. | β | 2017 | β |
| DNA Methylation and Hydroxymethylation Profile of CD34<sup>+</sup>-Enriched Cell Products Intended for Autologous CD34<sup>+</sup> Cell Transplantation. | Rozman JZ et al. | β | 2017 | β |
| DNA methylation: an epigenetic mark of cellular memory. | Kim M et al. | β | 2017 | β |
| Donor-Dependent and Other Nondefined Factors Have Greater Influence on the Hepatic Phenotype Than the Starting Cell Type in Induced Pluripotent Stem Cell Derived Hepatocyte-Like Cells. | Heslop JA et al. | β | 2017 | β |
| Dynamic Reorganization of Nucleosome Positioning in Somatic Cells after Transfer into Porcine Enucleated Oocytes. | Tao C et al. | β | 2017 | β |
| Editing the genome of hiPSC with CRISPR/Cas9: disease models. | Bassett AR | β | 2017 | β |
| Effect of small molecules on cell reprogramming. | Baranek M et al. | β | 2017 | β |
| Efficient Generation of Ξ²-Globin-Expressing Erythroid Cells Using Stromal Cell-Derived Induced Pluripotent Stem Cells from Patients with Sickle Cell Disease. | Uchida N et al. | β | 2017 | β |
| Engineering Concepts in Stem Cell Research. | Narayanan K et al. | β | 2017 | β |
| Engineering kidney cells: reprogramming and directed differentiation to renal tissues. | Kaminski MM et al. | β | 2017 | β |
| Epigenetics of cell fate reprogramming and its implications for neurological disorders modelling. | Grzybek M et al. | β | 2017 | β |
| Generation of Induced Progenitor-like Cells from Mature Epithelial Cells Using Interrupted Reprogramming. | Guo L et al. | β | 2017 | β |
| Generation of Neural Crest-Like Cells From Human Periodontal Ligament Cell-Derived Induced Pluripotent Stem Cells. | Tomokiyo A et al. | β | 2017 | β |
| Generation of trophoblast-like cells from the amnion inΒ vitro: A novel cellular model for trophoblast development. | Wei Y et al. | β | 2017 | β |
| Genes Associated with Pancreas Development and Function Maintain Open Chromatin in iPSCs Generated from Human Pancreatic Beta Cells. | Thurner M et al. | β | 2017 | β |
| Genetically Encoded Photoactuators and Photosensors for Characterization and Manipulation of Pluripotent Stem Cells. | Pomeroy JE et al. | β | 2017 | β |
| Glaucoma: Biological Trabecular and Neuroretinal Pathology with Perspectives of Therapy Innovation and Preventive Diagnosis. | Nuzzi R et al. | β | 2017 | β |
| High throughput sequencing identifies an imprinted gene, Grb10, associated with the pluripotency state in nuclear transfer embryonic stem cells. | Li H et al. | β | 2017 | β |
| Human Pluripotent Stem Cell-Derived <i>TSC2</i>-Haploinsufficient Smooth Muscle Cells Recapitulate Features of Lymphangioleiomyomatosis. | Julian LM et al. | β | 2017 | β |
| <i>Arabidopsis</i> ATXR2 deposits H3K36me3 at the promoters of <i>LBD</i> genes to facilitate cellular dedifferentiation. | Lee K et al. | β | 2017 | β |
| Immunological Issues After Stem Cell-Based Ξ² Cell Replacement. | Sordi V et al. | β | 2017 | β |
| Incomplete MyoD-induced transdifferentiation is associated with chromatin remodeling deficiencies. | Manandhar D et al. | β | 2017 | β |
| Induced Pluripotent Stem Cell for the Study and Treatment of Sickle Cell Anemia. | Junqueira Reis LC et al. | β | 2017 | β |
| Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications. | Yoshida Y et al. | β | 2017 | β |
| Induced pluripotent stem cells as a new getaway for bone tissue engineering: A systematic review. | Bastami F et al. | β | 2017 | β |
| Induced Pluripotent Stem Cells from Ovarian Tissue. | Salas S et al. | β | 2017 | β |
| Induced pluripotent stem cells reprogramming: Epigenetics and applications in the regenerative medicine. | Gomes KM et al. | β | 2017 | β |
| Inherent Immunogenicity or Lack Thereof of Pluripotent Stem Cells: Implications for Cell Replacement Therapy. | Chhabra A | β | 2017 | β |
| In Reply to the Letter to the Editor "Circumventricular Organ Origin of Hemangioblastoama; Hypothesis for Pathogenesis of Disease". | Ma D et al. | β | 2017 | β |
| Integrated analysis of hematopoietic differentiation outcomes and molecular characterization reveals unbiased differentiation capacity and minor transcriptional memory in HPC/HSC-iPSCs. | Gao S et al. | β | 2017 | β |
| Investigation of the pathogenesis of autoimmune diseases by iPS cells. | Natsumoto B et al. | β | 2017 | β |
| Lineage Reprogramming of Astroglial Cells from Different Origins into Distinct Neuronal Subtypes. | Chouchane M et al. | β | 2017 | β |
| Melanoma-Derived iPCCs Show Differential Tumorigenicity and Therapy Response. | Bernhardt M et al. | β | 2017 | β |
| MicroRNA-125b is a key epigenetic regulatory factor that promotes nuclear transfer reprogramming. | Zhang J et al. | β | 2017 | β |
| Molecular and functional resemblance of differentiated cells derived from isogenic human iPSCs and SCNT-derived ESCs. | Zhao MT et al. | β | 2017 | β |
| New approaches for direct conversion of patient fibroblasts into neural cells. | Gopalakrishnan S et al. | β | 2017 | β |
| Optical High Content Nanoscopy of Epigenetic Marks Decodes Phenotypic Divergence in Stem Cells. | Kim JJ et al. | β | 2017 | β |
| Partial Reprogramming of Pluripotent Stem Cell-Derived Cardiomyocytes into Neurons. | Chuang W et al. | β | 2017 | β |
| Pluripotent stem cells in neuropsychiatric disorders. | Soliman MA et al. | β | 2017 | β |
| Pluripotent stem cells to hepatocytes, the journey so far. | Palakkan AA et al. | β | 2017 | β |
| Preferential Lineage-Specific Differentiation of Osteoblast-Derived Induced Pluripotent Stem Cells into Osteoprogenitors. | Roberts CL et al. | β | 2017 | β |
| Primordial germ cell differentiation of nuclear transfer embryonic stem cells using surface modified electroconductive scaffolds. | Eslami-Arshaghi T et al. | β | 2017 | β |
| Producing tissue specific stem cells for regeneration: how YAP/TAZ may prove useful. | Henle SJ et al. | β | 2017 | β |
| Regulation of DNA demethylation by the XPC DNA repair complex in somatic and pluripotent stem cells. | Ho JJ et al. | β | 2017 | β |
| Reprogramming cells from Gulf War veterans into neurons to study Gulf War illness. | Qiang L et al. | β | 2017 | β |
| Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions. | Slamecka J et al. | β | 2017 | β |
| Reprogramming towards totipotency is greatly facilitated by synergistic effects of small molecules. | Miyamoto K et al. | β | 2017 | β |
| RNA Exosome Complex-Mediated Control of Redox Status in Pluripotent Stem Cells. | Skamagki M et al. | β | 2017 | β |
| Sirt6 Promotes DNA End Joining in iPSCs Derived from Old Mice. | Chen W et al. | β | 2017 | β |
| Skeletal Muscle Cell Induction from Pluripotent Stem Cells. | Kodaka Y et al. | β | 2017 | β |
| Skin-derived precursors from human subjects with Type 2 diabetes yield dysfunctional vascular smooth muscle cells. | Steinbach SK et al. | β | 2017 | β |
| Spinal cord injuries: how could cell therapy help? | Badner A et al. | β | 2017 | β |
| Stem cells in regenerative medicine - from laboratory to clinical application - the eye. | DΔ browska AM et al. | β | 2017 | β |
| Stem Cell Therapies in Retinal Disorders. | Garg A et al. | β | 2017 | β |
| Synergetic effects of DNA methylation and histone modification during mouse induced pluripotent stem cell generation. | Wang G et al. | β | 2017 | β |
| Taming Human Genetic Variability: Transcriptomic Meta-Analysis Guides the Experimental Design and Interpretation of iPSC-Based Disease Modeling. | Germain PL et al. | β | 2017 | β |
| Techniques for the induction of human pluripotent stem cell differentiation towards cardiomyocytes. | Lewandowski J et al. | β | 2017 | β |
| TET-Catalyzed 5-Hydroxymethylation Precedes HNF4A Promoter Choice during Differentiation of Bipotent Liver Progenitors. | Ancey PB et al. | β | 2017 | β |
| The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis. | Aldiri I et al. | β | 2017 | β |
| The potential of induced pluripotent stem cells as a tool to study skeletal dysplasias and cartilage-related pathologic conditions. | Liu H et al. | β | 2017 | β |
| The slippery slope of hematopoietic stem cell aging. | Wahlestedt M et al. | β | 2017 | β |
| The therapeutic potential of cell identity reprogramming for the treatment of aging-related neurodegenerative disorders. | Smith DK et al. | β | 2017 | β |
| Tissues Derived From Reprogrammed Wharton's Jelly Stem Cells of the Umbilical Cord Provide an Ideal Platform to Study the Effects of Glucose, Zika Virus, and Other Agents on the Fetus. | Fong CY et al. | β | 2017 | β |
| Transcriptomic and epigenomic differences in human induced pluripotent stem cells generated from six reprogramming methods. | Churko JM et al. | β | 2017 | β |
| Transplantation of mouse-induced pluripotent stem cells into the cochlea for the treatment of sensorineural hearing loss. | Chen J et al. | β | 2017 | β |
| Two factor-based reprogramming of rodent and human fibroblasts into Schwann cells. | Mazzara PG et al. | β | 2017 | β |
| Urine-Derived Stem Cells: The Present and the Future. | Ji X et al. | β | 2017 | β |
| Using induced pluripotent stem cells to explore genetic and epigenetic variation associated with Alzheimer's disease. | Imm J et al. | β | 2017 | β |
| Whole genome DNA methylation: beyond genes silencing. | Tirado-Magallanes R et al. | β | 2017 | β |
| ZSCAN10 expression corrects the genomic instability of iPSCs from aged donors. | Skamagki M et al. | β | 2017 | β |
| 10th anniversary of iPS cells: the challenges that lie ahead. | Aoi T | β | 2016 | β |
| 3D human tissue culture: modeling environmental effects on the stem cell epigenome. | Colacino JA | β | 2016 | β |
| Amniotic Fluid Stem Cells: A Novel Source for Modeling of Human Genetic Diseases. | Antonucci I et al. | β | 2016 | β |
| An EWS-FLI1-Induced Osteosarcoma Model Unveiled a Crucial Role of Impaired Osteogenic Differentiation on Osteosarcoma Development. | Komura S et al. | β | 2016 | β |
| An integrative analysis of reprogramming in human isogenic system identified a clone selection criterion. | Shutova MV et al. | β | 2016 | β |
| An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs. | Menon S et al. | β | 2016 | β |
| A review of Rett syndrome (RTT) with induced pluripotent stem cells. | Balachandar V et al. | β | 2016 | β |
| Beneath the sword of Damocles: regenerative medicine and the shadow of immunogenicity. | Fairchild PJ et al. | β | 2016 | β |
| Bioinformatic and Genomic Analyses of Cellular Reprogramming and Direct Lineage Conversion. | Kareta MS | β | 2016 | β |
| Blockade of senescence-associated microRNA-195 in aged skeletal muscle cells facilitates reprogramming to produce induced pluripotent stem cells. | Kondo H et al. | β | 2016 | β |
| Blood Derived Induced Pluripotent Stem Cells (iPSCs): Benefits, Challenges and the Road Ahead. | El Hokayem J et al. | β | 2016 | β |
| Cell-of-Origin-Specific 3D Genome Structure Acquired during Somatic Cell Reprogramming. | Krijger PH et al. | β | 2016 | β |
| Cell type of origin influences iPSC generation and differentiation to cells of the hematoendothelial lineage. | Phetfong J et al. | β | 2016 | β |
| Cellular Ontogeny and Hierarchy Influence the Reprogramming Efficiency of Human B Cells into Induced Pluripotent Stem Cells. | MuΓ±oz-LΓ³pez Γ et al. | β | 2016 | β |
| Choices for Induction of Pluripotency: Recent Developments in Human Induced Pluripotent Stem Cell Reprogramming Strategies. | Brouwer M et al. | β | 2016 | β |
| Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative Diseases. | Haston KM et al. | β | 2016 | β |
| CMD kinetics and regenerative medicine. | Anjamrooz SH | β | 2016 | β |
| Cognition, Information Fields and Hologenomic Entanglement: Evolution in Light and Shadow. | Miller WB | β | 2016 | β |
| Computational Tools for Stem Cell Biology. | Bian Q et al. | β | 2016 | β |
| Concise Review: Exciting Cells: Modeling Genetic Epilepsies with Patient-Derived Induced Pluripotent Stem Cells. | Tidball AM et al. | β | 2016 | β |
| Concise Review: Patient-Derived Stem Cell Research for Monogenic Disorders. | Qin Y et al. | β | 2016 | β |
| Converting cell fates: generating hematopoietic stem cells de novo via transcription factor reprogramming. | Daniel MG et al. | β | 2016 | β |
| Converting Skin Fibroblasts into Hepatic-like Cells by Transient Programming. | Zhu XQ et al. | β | 2016 | β |
| Cultivate Primary Nasal Epithelial Cells from Children and Reprogram into Induced Pluripotent Stem Cells. | Ulm A et al. | β | 2016 | β |
| Current advances in the generation of human iPS cells: implications in cell-based regenerative medicine. | Revilla A et al. | β | 2016 | β |
| Current Cell-Based Strategies for Whole Kidney Regeneration. | Poornejad N et al. | β | 2016 | β |
| Cynomolgus Monkey Induced Pluripotent Stem Cells Generated By Using Allogeneic Genes. | Shimozawa N | β | 2016 | β |
| Cytoskeletal Expression and Remodeling in Pluripotent Stem Cells. | Boraas LC et al. | β | 2016 | β |
| Differential Regulation of SOX9 Protein During Chondrogenesis of Induced Pluripotent Stem Cells Versus Mesenchymal Stromal Cells: A Shortcoming for Cartilage Formation. | Diederichs S et al. | β | 2016 | β |
| Differentiation of Human Induced-Pluripotent Stem Cells into Smooth-Muscle Cells: Two Novel Protocols. | Yang L et al. | β | 2016 | β |
| DNA methylation dynamics in cellular commitment and differentiation. | Suelves M et al. | β | 2016 | β |
| DNA methylation dynamics in human induced pluripotent stem cells. | Nishino K et al. | β | 2016 | β |
| DNA Methylation Signature of Post-injury Neointimal Cells During Vascular Remodeling in the Rat Balloon Injury Model. | Richards J et al. | β | 2016 | β |
| Echoes of the embryo: using the developmental biology toolkit to study cancer. | Aiello NM et al. | β | 2016 | β |
| Editing the epigenome: technologies for programmable transcription and epigenetic modulation. | Thakore PI et al. | β | 2016 | β |
| Effects of cellular origin on differentiation of human induced pluripotent stem cell-derived endothelial cells. | Hu S et al. | β | 2016 | β |
| Efficient and versatile CRISPR engineering of human neurons in culture to model neurological disorders. | Shah RR et al. | β | 2016 | β |
| Enrichment of Oligodendrocyte Progenitors from Differentiated Neural Precursors by Clonal Sphere Preparations. | Umebayashi D et al. | β | 2016 | β |
| Epigenetic Aberrations Are Not Specific to Transcription Factor-Mediated Reprogramming. | Tiemann U et al. | β | 2016 | β |
| Epigenetic Research of Neurodegenerative Disorders Using Patient iPSC-Based Models. | FernΓ‘ndez-Santiago R et al. | β | 2016 | β |
| Epigenetics of Renal Development and Disease. | Hilliard SA et al. | β | 2016 | β |
| Epigenetic Variation between Human Induced Pluripotent Stem Cell Lines Is an Indicator of Differentiation Capacity. | Nishizawa M et al. | β | 2016 | β |
| Establishment of Human Neural Progenitor Cells from Human Induced Pluripotent Stem Cells with Diverse Tissue Origins. | Fukusumi H et al. | β | 2016 | β |
| FoxO3 regulates neuronal reprogramming of cells from postnatal and aging mice. | Ahlenius H et al. | β | 2016 | β |
| Functional comparison of human embryonic stem cells and induced pluripotent stem cells as sources of hepatocyte-like cells. | Jeong J et al. | β | 2016 | β |
| Functional Neurons Generated from T Cell-Derived Induced Pluripotent Stem Cells for Neurological Disease Modeling. | Matsumoto T et al. | β | 2016 | β |
| Generation and periodontal differentiation of human gingival fibroblasts-derived integration-free induced pluripotent stem cells. | Yin X et al. | β | 2016 | β |
| Generation of diverse neural cell types through direct conversion. | Petersen GF et al. | β | 2016 | β |
| Generation of Human Lens Epithelial-Like Cells From Patient-Specific Induced Pluripotent Stem Cells. | Li D et al. | β | 2016 | β |
| Generation of induced pluripotent stem cells from human mesenchymal stem cells of parotid gland origin. | Yan X et al. | β | 2016 | β |
| Genetic Variability Overrides the Impact of Parental Cell Type and Determines iPSC Differentiation Potential. | KyttΓ€lΓ€ A et al. | β | 2016 | β |
| Genetic Variation, Not Cell Type of Origin, Underlies the Majority of Identifiable Regulatory Differences in iPSCs. | Burrows CK et al. | β | 2016 | β |
| Genome-Wide Transcriptome and Binding Sites Analyses Identify Early FOX Expressions for Enhancing Cardiomyogenesis Efficiency of hESC Cultures. | Yeo HC et al. | β | 2016 | β |
| Genomic stability during cellular reprogramming: Mission impossible? | von Joest M et al. | β | 2016 | β |
| H1foo Has a Pivotal Role in Qualifying Induced Pluripotent Stem Cells. | Kunitomi A et al. | β | 2016 | β |
| How iPS cells changed the world. | Scudellari M | β | 2016 | β |
| Human Embryonic Stem Cells: A Model for the Study of Neural Development and Neurological Diseases. | Prajumwongs P et al. | β | 2016 | β |
| Human Hepatocyte-Derived Induced Pluripotent Stem Cells: MYC Expression, Similarities to Human Germ Cell Tumors, and Safety Issues. | Unzu C et al. | β | 2016 | β |
| Human induced pluripotent stem cells for monogenic disease modelling and therapy. | Spitalieri P et al. | β | 2016 | β |
| Induced Pluripotent Stem Cell as a New Source for Cancer Immunotherapy. | Rami F et al. | β | 2016 | β |
| Induced Pluripotent Stem Cell Differentiation and Three-Dimensional Tissue Formation Attenuate Clonal Epigenetic Differences in Trichohyalin. | Petrova A et al. | β | 2016 | β |
| Induced Pluripotent Stem Cells and Outer Retinal Disease. | Yang J et al. | β | 2016 | β |
| Induced Pluripotent Stem Cells Can Effectively Differentiate into Multiple Functional Lymphocyte Lineages In Vivo with Negligible Bias. | Lan T et al. | β | 2016 | β |
| Induced Pluripotent Stem Cells: Generation Strategy and Epigenetic Mystery behind Reprogramming. | Ji P et al. | β | 2016 | β |
| Induced Pluripotent Stem Cells inΒ Huntington's Disease Research: ProgressΒ and Opportunity. | Tousley A et al. | β | 2016 | β |
| Induced Pluripotent Stem Cells Meet Genome Editing. | Hockemeyer D et al. | β | 2016 | β |
| Induced Pluripotent Stem Cell Therapies for Cervical Spinal Cord Injury. | Doulames VM et al. | β | 2016 | β |
| Induced pluripotent stem (iPS) cells from human fetal stem cells. | Guillot PV | β | 2016 | β |
| Induced Pluripotent Stem (iPS) Cells in Dentistry: A Review. | Malhotra N | β | 2016 | β |
| Injectable calcium phosphate with hydrogel fibers encapsulating induced pluripotent, dental pulp and bone marrow stem cells for bone repair. | Wang L et al. | β | 2016 | β |
| Insulin Resistance in Human iPS Cells Reduces Mitochondrial Size and Function. | Burkart AM et al. | β | 2016 | β |
| [In vitro generation of blood red cells from stem cells: a sketch of the future]. | Mazurier C et al. | β | 2016 | β |
| In vitro models of cancer stem cells and clinical applications. | S Franco S et al. | β | 2016 | β |
| iPS Cells-The Triumphs and Tribulations. | Sharma R | β | 2016 | β |
| iPSCs: A Minireview from Bench to Bed, including Organoids and the CRISPR System. | Orqueda AJ et al. | β | 2016 | β |
| Limbal Stem Cell Deficiency: Current Treatment Options and Emerging Therapies. | Haagdorens M et al. | β | 2016 | β |
| Local Genome Topology Can Exhibit an Incompletely Rewired 3D-Folding State during Somatic Cell Reprogramming. | Beagan JA et al. | β | 2016 | β |
| Looping around Reprogramming: The Topological Memory of Induced Pluripotency. | Gonzales KA et al. | β | 2016 | β |
| Making a Hematopoietic Stem Cell. | Daniel MG et al. | β | 2016 | β |
| Mapping Human Pluripotent-to-Cardiomyocyte Differentiation: Methylomes, Transcriptomes, and Exon DNA Methylation "Memories". | Tompkins JD et al. | β | 2016 | β |
| Metaboloepigenetic Regulation of Pluripotent Stem Cells. | Harvey AJ et al. | β | 2016 | β |
| Mitochondria in pluripotent stem cells: stemness regulators and disease targets. | Folmes CD et al. | β | 2016 | β |
| Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells. | Mungenast AE et al. | β | 2016 | β |
| Modeling neurological diseases with induced pluripotent cells reprogrammed from immortalized lymphoblastoid cell lines. | Fujimori K et al. | β | 2016 | β |
| Modulation of human allogeneic and syngeneic pluripotent stem cells and immunological implications for transplantation. | Sackett SD et al. | β | 2016 | β |
| Molecular Obstacles to Clinical Translation of iPSCs. | Tapia N et al. | β | 2016 | β |
| Non-CG DNA methylation is a biomarker for assessing endodermal differentiation capacity in pluripotent stem cells. | Butcher LM et al. | β | 2016 | β |
| Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions. | Slamecka J et al. | β | 2016 | β |
| Novel 3D Culture Systems for Studies of Human Liver Function and Assessments of the Hepatotoxicity of Drugs and Drug Candidates. | Lauschke VM et al. | β | 2016 | β |
| Nuclear reprogramming and cell replacement therapies. | Gurdon JB | β | 2016 | β |
| One Standardized Differentiation Procedure Robustly Generates Homogenous Hepatocyte Cultures Displaying Metabolic Diversity from a Large Panel of Human Pluripotent Stem Cells. | Asplund A et al. | β | 2016 | β |
| Patient-Derived Human Induced Pluripotent Stem Cells From Gingival Fibroblasts Composited With Defined Nanohydroxyapatite/Chitosan/Gelatin Porous Scaffolds as Potential Bone Graft Substitutes. | Ji J et al. | β | 2016 | β |
| Patient-derived induced pluripotent stem cells in cancer research and precision oncology. | Papapetrou EP | β | 2016 | β |
| Phosphatidic Acid Improves Reprogramming to Pluripotency by Reducing Apoptosis. | Jiang Y et al. | β | 2016 | β |
| Pluripotent stem cell-derived kidney organoids: An in vivo-like in vitro technology. | Schutgens F et al. | β | 2016 | β |
| Pluripotent Stem Cells: Current Understanding and Future Directions. | Romito A et al. | β | 2016 | β |
| Pluripotent stem cells: the last 10 years. | Kimbrel EA et al. | β | 2016 | β |
| RE1-silencing Transcription Factor (REST) Is Required for Nuclear Reprogramming by Inhibiting Transforming Growth Factor Ξ² Signaling Pathway. | Kong QR et al. | β | 2016 | β |
| Reactivation of Endogenous Genes and Epigenetic Remodeling Are Barriers for Generating Transgene-Free Induced Pluripotent Stem Cells in Pig. | Choi KH et al. | β | 2016 | β |
| Recent progress towards understanding the role of DNA methylation in human placental development. | Bianco-Miotto T et al. | β | 2016 | β |
| Repressed SIRT1/PGC-1Ξ± pathway and mitochondrial disintegration in iPSC-derived RPE disease model of age-related macular degeneration. | Golestaneh N et al. | β | 2016 | β |
| Reprogramming cancer cells: overview & current progress. | Lim KL et al. | β | 2016 | β |
| Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program. | Daniel MG et al. | β | 2016 | β |
| Reprogramming of mouse retinal neurons and standardized quantification of their differentiation in 3D retinal cultures. | Hiler DJ et al. | β | 2016 | β |
| Review: Induced pluripotent stem cell models of frontotemporal dementia. | Preza E et al. | β | 2016 | β |
| Role of Epigenetics in Stem Cell Proliferation and Differentiation: Implications for Treating Neurodegenerative Diseases. | Srinageshwar B et al. | β | 2016 | β |
| Role of Histone-Modifying Enzymes and Their Complexes in Regulation of Chromatin Biology. | DesJarlais R et al. | β | 2016 | β |
| Single-cell multimodal profiling reveals cellular epigenetic heterogeneity. | Cheow LF et al. | β | 2016 | β |
| Stem and Progenitor Cell-Based Therapy of the Central Nervous System: Hopes, Hype, and Wishful Thinking. | Goldman SA | β | 2016 | β |
| Stem Cells in Skeletal Tissue Engineering: Technologies and Models. | Langhans MT et al. | β | 2016 | β |
| Stem Cell Therapies for Treatment of Liver Disease. | Nicolas C et al. | β | 2016 | β |
| Stem Cell Therapy for Treatment of Ocular Disorders. | Sivan PP et al. | β | 2016 | β |
| Strong Components of Epigenetic Memory in Cultured Human Fibroblasts Related to Site of Origin and Donor Age. | Ivanov NA et al. | β | 2016 | β |
| Survivin Improves Reprogramming Efficiency of Human Neural Progenitors by Single Molecule OCT4. | Zhou S et al. | β | 2016 | β |
| Tankyrase inhibition promotes a stable human naΓ―ve pluripotent state with improved functionality. | Zimmerlin L et al. | β | 2016 | β |
| Targeted Epigenetic Remodeling of Endogenous Loci by CRISPR/Cas9-Based Transcriptional Activators Directly Converts Fibroblasts to Neuronal Cells. | Black JB et al. | β | 2016 | β |
| T Cell Genesis: In Vitro Veritas Est? | Brauer PM et al. | β | 2016 | β |
| Techniques of Human Embryonic Stem Cell and Induced Pluripotent Stem Cell Derivation. | Lewandowski J et al. | β | 2016 | β |
| The Aberrant DNA Methylation Profile of Human Induced Pluripotent Stem Cells Is Connected to the Reprogramming Process and Is Normalized During In Vitro Culture. | Tesarova L et al. | β | 2016 | β |
| The hematopoietic system in the context of regenerative medicine. | Porada CD et al. | β | 2016 | β |
| The mitochondrial protein CHCHD2 primes the differentiation potential of human induced pluripotent stem cells to neuroectodermal lineages. | Zhu L et al. | β | 2016 | β |
| The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications. | Youssef AA et al. | β | 2016 | β |
| The significance of cell-related challenges in the clinical application of tissue engineering. | Almela T et al. | β | 2016 | β |
| The Use of Induced Pluripotent Stem Cells for the Study and Treatment of Liver Diseases. | Hansel MC et al. | β | 2016 | β |
| Tissue-Specific Stem Cells Obtained by Reprogramming of Non-Obese Diabetic (NOD) Mouse-Derived Pancreatic Cells Confer Insulin Production in Response to Glucose. | Saitoh I et al. | β | 2016 | β |
| Transcriptional and epigenetic mechanisms of cellular reprogramming to induced pluripotency. | van den Hurk M et al. | β | 2016 | β |
| Transcriptional comparison of human induced and primary midbrain dopaminergic neurons. | Xia N et al. | β | 2016 | β |
| Tumorigenic potential is restored during differentiation in fusion-reprogrammed cancer cells. | Yao J et al. | β | 2016 | β |
| Understanding the Complex Circuitry of lncRNAs at the X-inactivation Center and Its Implications in Disease Conditions. | Richard JL et al. | β | 2016 | β |
| Urine-derived induced pluripotent stem cells as a modeling tool to study rare human diseases. | Shi L et al. | β | 2016 | β |
| A bibliometric analysis of publications on pluripotent stem cell research. | Lin CL et al. | β | 2015 | β |
| Advances in reprogramming-based study of neurologic disorders. | Nityanandam A et al. | β | 2015 | β |
| Alternative Routes to Induce NaΓ―ve Pluripotency in Human Embryonic Stem Cells. | Duggal G et al. | β | 2015 | β |
| A Systemized Approach to Investigate Ca(2+) Synchronization in Clusters of Human Induced Pluripotent Stem-Cell Derived Cardiomyocytes. | Jones AR et al. | β | 2015 | β |
| Avoiding immunological rejection in regenerative medicine. | Bolton EM et al. | β | 2015 | β |
| Can cord blood banks transform into induced pluripotent stem cell banks? | Zhou H et al. | β | 2015 | β |
| Canonical MicroRNA Activity Facilitates but May Be Dispensable for Transcription Factor-Mediated Reprogramming. | Liu Z et al. | β | 2015 | β |
| Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells. | Tanaka A et al. | β | 2015 | β |
| Cell Adhesion Minimization by a Novel Mesh Culture Method Mechanically Directs Trophoblast Differentiation and Self-Assembly Organization of Human Pluripotent Stem Cells. | Okeyo KO et al. | β | 2015 | β |
| Cell divisions are not essential for the direct conversion of fibroblasts into neuronal cells. | Fishman VS et al. | β | 2015 | β |
| Cell memory-based therapy. | Anjamrooz SH | β | 2015 | β |
| Cell replacement therapy for central nervous system diseases. | Tso D et al. | β | 2015 | β |
| Cellular strategies for retinal repair by photoreceptor replacement. | Jayakody SA et al. | β | 2015 | β |
| Characterization of human neural differentiation from pluripotent stem cells using proteomics/PTMomics--current state-of-the-art and challenges. | Melo-Braga MN et al. | β | 2015 | β |
| Concise Review: Methods and Cell Types Used to Generate Down Syndrome Induced Pluripotent Stem Cells. | Hibaoui Y et al. | β | 2015 | β |
| Concise Review: Understanding the Renal Progenitor Cell Niche In Vivo to Recapitulate Nephrogenesis In Vitro. | Mari C et al. | β | 2015 | β |
| Conversion of mouse fibroblasts into cardiomyocyte-like cells using small molecule treatments. | Park G et al. | β | 2015 | β |
| Databases and collaboration require standards for human stem cell research. | Litterman NK et al. | β | 2015 | β |
| Derivation and high engraftment of patient-specific cardiomyocyte sheet using induced pluripotent stem cells generated from adult cardiac fibroblast. | Zhang L et al. | β | 2015 | β |
| Derivation of Endodermal Progenitors From Pluripotent Stem Cells. | Ikonomou L et al. | β | 2015 | β |
| Derivation of hair-inducing cell from human pluripotent stem cells. | Gnedeva K et al. | β | 2015 | β |
| Development of a protein marker panel for characterization of human induced pluripotent stem cells (hiPSCs) using global quantitative proteome analysis. | Pripuzova NS et al. | β | 2015 | β |
| Development of stem cell-based therapy for Parkinson's disease. | Han F et al. | β | 2015 | β |
| Direct conversion of human myoblasts into brown-like adipocytes by engineered super-active PPARΞ³. | Zhu Y et al. | β | 2015 | β |
| Direct Conversion of Normal and Alzheimer's Disease Human Fibroblasts into Neuronal Cells by Small Molecules. | Hu W et al. | β | 2015 | β |
| Direct Induction of Trophoblast Stem Cells from Murine Fibroblasts. | Kubaczka C et al. | β | 2015 | β |
| Dissecting the role of aberrant DNA methylation in human leukaemia. | Amabile G et al. | β | 2015 | β |
| DNA methylation and hydroxymethylation in stem cells. | Cheng Y et al. | β | 2015 | β |
| DNA Methylation Dynamics During Differentiation, Proliferation, and Tumorigenesis in the Intestinal Tract. | Huang CZ et al. | β | 2015 | β |
| DNA methylation signature in peripheral blood reveals distinct characteristics of human X chromosome numerical aberrations. | Sharma A et al. | β | 2015 | β |
| Dynamic transcriptional and epigenomic reprogramming from pediatric nasal epithelial cells to induced pluripotent stem cells. | Ji H et al. | β | 2015 | β |
| Effects of downregulating GLIS1 transcript on preimplantation development and gene expression of bovine embryos. | Takahashi K et al. | β | 2015 | β |
| Enhanced MyoD-induced transdifferentiation to a myogenic lineage by fusion to a potent transactivation domain. | Kabadi AM et al. | β | 2015 | β |
| Equine Induced Pluripotent Stem Cells have a Reduced Tendon Differentiation Capacity Compared to Embryonic Stem Cells. | Bavin EP et al. | β | 2015 | β |
| Erythroid differentiation of human induced pluripotent stem cells is independent of donor cell type of origin. | Dorn I et al. | β | 2015 | β |
| Ethical considerations in stem cell research on neurologic and orthopedic conditions. | Banja JD | β | 2015 | β |
| Familial Dysautonomia (FD) Human Embryonic Stem Cell Derived PNS Neurons Reveal that Synaptic Vesicular and Neuronal Transport Genes Are Directly or Indirectly Affected by IKBKAP Downregulation. | Lefler S et al. | β | 2015 | β |
| Fluctuations in histone H4 isoforms during cellular reprogramming monitored by middle-down proteomics. | Benevento M et al. | β | 2015 | β |
| Function and significance of MicroRNAs in benign and malignant human stem cells. | Utikal J et al. | β | 2015 | β |
| Generating a self-organizing kidney from pluripotent cells. | Little MH et al. | β | 2015 | β |
| Generating induced pluripotent stem cell derived endothelial cells and induced endothelial cells for cardiovascular disease modelling and therapeutic angiogenesis. | Clayton ZE et al. | β | 2015 | β |
| Generation of embryonic stem cells from mouse adipose-tissue derived cells via somatic cell nuclear transfer. | Qin Y et al. | β | 2015 | β |
| Generation of Induced Pluripotent Stem Cells from Frozen Buffy Coats using Non-integrating Episomal Plasmids. | Meraviglia V et al. | β | 2015 | β |
| Generation of induced pluripotent stem cells without genetic defects by small molecules. | Park HS et al. | β | 2015 | β |
| Genetic heterogeneity of induced pluripotent stem cells: results from 24 clones derived from a single C57BL/6 mouse. | Li C et al. | β | 2015 | β |
| Glia Disease and Repair-Remyelination. | Franklin RJ et al. | β | 2015 | β |
| Hallmarks of pluripotency. | De Los Angeles A et al. | β | 2015 | β |
| Histone deacetylase inhibition protects hearing against acute ototoxicity by activating the Nf-<i>ΞΊ</i>B pathway. | Layman WS et al. | β | 2015 | β |
| Humanized Mice Reveal Differential Immunogenicity of Cells Derived from Autologous Induced Pluripotent Stem Cells. | Zhao T et al. | β | 2015 | β |
| Human Ocular Epithelial Cells Endogenously Expressing SOX2 and OCT4 Yield High Efficiency of Pluripotency Reprogramming. | Poon MW et al. | β | 2015 | β |
| Immunogenicity and functional evaluation of iPSC-derived organs for transplantation. | Wang L et al. | β | 2015 | β |
| Improvement of In Vitro Osteogenic Potential through Differentiation of Induced Pluripotent Stem Cells from Human Exfoliated Dental Tissue towards Mesenchymal-Like Stem Cells. | Ishiy FA et al. | β | 2015 | β |
| Induced myogenic commitment of human chondrocytes via non-viral delivery of minicircle DNA. | Hong J et al. | β | 2015 | β |
| Induced Pluripotency and Epigenetic Reprogramming. | Hochedlinger K et al. | β | 2015 | β |
| Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and Challenges. | Seah YF et al. | β | 2015 | β |
| Induced Pluripotent Stem Cells: A New Frontier for Stem Cells in Dentistry. | Hynes K et al. | β | 2015 | β |
| Induced pluripotent stem cells for cardiovascular disease: from product-focused disease modeling to process-focused disease discovery. | Campbell KA et al. | β | 2015 | β |
| Induction of Pluripotency in Astrocytes through a Neural Stem Cell-like State. | Nakajima-Koyama M et al. | β | 2015 | β |
| Induction of tissue-specific stem cells by reprogramming factors, and tissue-specific selection. | Noguchi H et al. | β | 2015 | β |
| Large-scale production of lentiviral vector in a closed system hollow fiber bioreactor. | Sheu J et al. | β | 2015 | β |
| Letter by Li and Hao Regarding Article, "Transdifferentiation of Human Fibroblasts to Endothelial Cells: Role of Innate Immunity". | Li Y et al. | β | 2015 | β |
| Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia. | Antony-DebrΓ© I et al. | β | 2015 | β |
| Maternal histone variants and their chaperones promote paternal genome activation and boost somatic cell reprogramming. | Yang P et al. | β | 2015 | β |
| Mesodermal iPSC-derived progenitor cells functionally regenerate cardiac and skeletal muscle. | Quattrocelli M et al. | β | 2015 | β |
| Methods of induced pluripotent stem cells for clinical application. | Seki T et al. | β | 2015 | β |
| Modeling Human Bone Marrow Failure Syndromes Using Pluripotent Stem Cells and Genome Engineering. | Jung M et al. | β | 2015 | β |
| Modeling Kidney Disease with iPS Cells. | Freedman BS | β | 2015 | β |
| Mouse-human experimental epigenetic analysis unmasks dietary targets and genetic liability for diabetic phenotypes. | Multhaup ML et al. | β | 2015 | β |
| Multiple sclerosis: getting personal with induced pluripotent stem cells. | Di Ruscio A et al. | β | 2015 | β |
| NaΓ―ve-like conversion enhances the difference in innate in vitro differentiation capacity between rabbit ES cells and iPS cells. | Honsho K et al. | β | 2015 | β |
| Neural Differentiation of Human Pluripotent Stem Cells for Nontherapeutic Applications: Toxicology, Pharmacology, and In Vitro Disease Modeling. | Yap MS et al. | β | 2015 | β |
| NF-ΞΊB activation impairs somatic cell reprogramming in ageing. | Soria-Valles C et al. | β | 2015 | β |
| Non-human primate and rodent embryonic stem cells are differentially sensitive to embryotoxic compounds. | Walker L et al. | β | 2015 | β |
| Novel Human Embryonic Stem Cell Regulators Identified by Conserved and Distinct CpG Island Methylation State. | Pells S et al. | β | 2015 | β |
| Periodontal ligament stem cells: current status, concerns, and future prospects. | Zhu W et al. | β | 2015 | β |
| Pluripotency, Differentiation, and Reprogramming: A Gene Expression Dynamics Model with Epigenetic Feedback Regulation. | Miyamoto T et al. | β | 2015 | β |
| Pluripotent stem cell-based disease modeling: current hurdles and future promise. | Zeltner N et al. | β | 2015 | β |
| Pluripotent stem cell energy metabolism: an update. | Teslaa T et al. | β | 2015 | β |
| Pluripotent stem cells derived from mouse primordial germ cells by small molecule compounds. | Kimura T et al. | β | 2015 | β |
| Potential Factors for the Differentiation of ESCs/iPSCs Into Insulin-Producing Cells. | Tsugata T et al. | β | 2015 | β |
| Preferential gene expression and epigenetic memory of induced pluripotent stem cells derived from mouse pancreas. | Nukaya D et al. | β | 2015 | β |
| Present and future challenges of induced pluripotent stem cells. | Ohnuki M et al. | β | 2015 | β |
| Preventing ototoxic hearing loss by inhibiting histone deacetylases. | Layman WS et al. | β | 2015 | β |
| Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient iPSCs After Genome Editing of the Sickle Point Mutation. | Huang X et al. | β | 2015 | β |
| Programming and Reprogramming Cellular Age in the Era of Induced Pluripotency. | Studer L et al. | β | 2015 | β |
| Prospects for clinical use of reprogrammed cells for autologous treatment of macular degeneration. | Alvarez Palomo AB et al. | β | 2015 | β |
| Putting induced pluripotent stem cells to the test. | Vallier L | β | 2015 | β |
| Quantification of Retinogenesis in 3D Cultures Reveals Epigenetic Memory and Higher Efficiency in iPSCs Derived from Rod Photoreceptors. | Hiler D et al. | β | 2015 | β |
| Re-epithelialization: a key element in tracheal tissue engineering. | Zhang H et al. | β | 2015 | β |
| Reprogramming and transdifferentiation for cardiovascular development and regenerative medicine: where do we stand? | Ebert AD et al. | β | 2015 | β |
| Reprogramming cancer cells: a novel approach for cancer therapy or a tool for disease-modeling? | Yilmazer A et al. | β | 2015 | β |
| Research on induced pluripotent stem cells and the application in ocular tissues. | Guo XL et al. | β | 2015 | β |
| Severe insulin resistance alters metabolism in mesenchymal progenitor cells. | Balhara B et al. | β | 2015 | β |
| Single-cell transcriptome analysis reveals dynamic changes in lncRNA expression during reprogramming. | Kim DH et al. | β | 2015 | β |
| SOX2 and SOX2-MYC Reprogramming Process of Fibroblasts to the Neural Stem Cells Compromised by Senescence. | Winiecka-Klimek M et al. | β | 2015 | β |
| Stem cell-derived systems in toxicology assessment. | Suter-Dick L et al. | β | 2015 | β |
| Stress as a fundamental theme in cell plasticity. | Shoshani O et al. | β | 2015 | β |
| Striatal Transplantation of Human Dopaminergic Neurons Differentiated From Induced Pluripotent Stem Cells Derived From Umbilical Cord Blood Using Lentiviral Reprogramming. | Effenberg A et al. | β | 2015 | β |
| Tet-mediated imprinting erasure in H19 locus following reprogramming of spermatogonial stem cells to induced pluripotent stem cells. | Bermejo-Γlvarez P et al. | β | 2015 | β |
| The combination of Tet1 with Oct4 generates high-quality mouse-induced pluripotent stem cells. | Chen J et al. | β | 2015 | β |
| The epigenetics of aging and neurodegeneration. | Lardenoije R et al. | β | 2015 | β |
| The Lineage-Specific Transcription Factor PU.1 Prevents Polycomb-Mediated Heterochromatin Formation at Macrophage-Specific Genes. | Tagore M et al. | β | 2015 | β |
| THERAPY OF ENDOCRINE DISEASE: Islet transplantation for type 1 diabetes: so close and yet so far away. | Khosravi-Maharlooei M et al. | β | 2015 | β |
| Transcription factor-mediated reprogramming: epigenetics and therapeutic potential. | Firas J et al. | β | 2015 | β |
| Transcription factor-mediated reprogramming toward hematopoietic stem cells. | Ebina W et al. | β | 2015 | β |
| Understanding the Molecular Basis of Heterogeneity in Induced Pluripotent Stem Cells. | Manian KV et al. | β | 2015 | β |
| Using iPS Cells toward the Understanding of Parkinson's Disease. | Torrent R et al. | β | 2015 | β |
| Variations in the Intragene Methylation Profiles Hallmark Induced Pluripotency. | Druzhkov P et al. | β | 2015 | β |
| Wiskott-Aldrich syndrome iPS cells produce megakaryocytes with defects in cytoskeletal rearrangement and proplatelet formation. | Ingrungruanglert P et al. | β | 2015 | β |
| 5-methylcytosine and its derivatives. | Yuan BF | β | 2014 | β |
| Abnormalities in human pluripotent cells due to reprogramming mechanisms. | Ma H et al. | β | 2014 | β |
| A Comparative View on Human Somatic Cell Sources for iPSC Generation. | Raab S et al. | β | 2014 | β |
| Advances in understanding the cell types and approaches used for generating induced pluripotent stem cells. | Li J et al. | β | 2014 | β |
| Airway tissue engineering: an update. | Fishman JM et al. | β | 2014 | β |
| Cell reprogramming. Histone chaperone ASF1A is required for maintenance of pluripotency and cellular reprogramming. | Gonzalez-MuΓ±oz E et al. | β | 2014 | β |
| Comparing ESC and iPSC-Based Models for Human Genetic Disorders. | Halevy T et al. | β | 2014 | β |
| Concise review: tissue-specific microvascular endothelial cells derived from human pluripotent stem cells. | Wilson HK et al. | β | 2014 | β |
| Deciphering the heterogeneity in DNA methylation patterns during stem cell differentiation and reprogramming. | Shao X et al. | β | 2014 | β |
| Deep sequencing reveals low incidence of endogenous LINE-1 retrotransposition in human induced pluripotent stem cells. | Arokium H et al. | β | 2014 | β |
| Defining differentially methylated regions specific for the acquisition of pluripotency and maintenance in human pluripotent stem cells via microarray. | He W et al. | β | 2014 | β |
| Directed differentiation of pluripotent stem cells to kidney cells. | Lam AQ et al. | β | 2014 | β |
| Disease-in-a-dish: the contribution of patient-specific induced pluripotent stem cell technology to regenerative rehabilitation. | Mack DL et al. | β | 2014 | β |
| Divergent reprogramming routes lead to alternative stem-cell states. | Tonge PD et al. | β | 2014 | β |
| Dynamic and static maintenance of epigenetic memory in pluripotent and somatic cells. | Shipony Z et al. | β | 2014 | β |
| Effect of human donor cell source on differentiation and function of cardiac induced pluripotent stem cells. | Sanchez-Freire V et al. | β | 2014 | β |
| Emerging trends and new developments in regenerative medicine: a scientometric update (2000 - 2014). | Chen C et al. | β | 2014 | β |
| Epigenetic memory in somatic cell nuclear transfer and induced pluripotency: evidence and implications. | Firas J et al. | β | 2014 | β |
| Epigenetic regulation in the inner ear and its potential roles in development, protection, and regeneration. | Layman WS et al. | β | 2014 | β |
| Epigenetic regulation of adult neural stem cells: implications for Alzheimer's disease. | Fitzsimons CP et al. | β | 2014 | β |
| Epigenetic regulation of hematopoietic stem cell aging. | Beerman I et al. | β | 2014 | β |
| Epigenetic regulation of pluripotency and differentiation. | Boland MJ et al. | β | 2014 | β |
| Epigenetic resolution of the 'curse of complexity' in adaptive evolution of complex traits. | Badyaev AV | β | 2014 | β |
| Epigenetic setting and reprogramming for neural cell fate determination and differentiation. | Imamura T et al. | β | 2014 | β |
| Equine induced pluripotent stem cells or how to turn skin cells into neurons: horse tissues a la carte? | Donadeu FX | β | 2014 | β |
| Establishment of human cell type-specific iPS cells with enhanced chondrogenic potential. | Guzzo RM et al. | β | 2014 | β |
| Generation of human Ξ²-thalassemia induced pluripotent cell lines by reprogramming of bone marrow-derived mesenchymal stromal cells using modified mRNA. | Varela I et al. | β | 2014 | β |
| Generation of induced pluripotent stem cells from virus-free in vivo reprogramming of BALB/c mouse liver cells. | de LΓ‘zaro I et al. | β | 2014 | β |
| Genetic background drives transcriptional variation in human induced pluripotent stem cells. | Rouhani F et al. | β | 2014 | β |
| Genomic editing tools to model human diseases with isogenic pluripotent stem cells. | Kim HS et al. | β | 2014 | β |
| GM-CSF and MEF-conditioned media support feeder-free reprogramming of mouse granulocytes to iPS cells. | Firas J et al. | β | 2014 | β |
| Hierarchical molecular events driven by oocyte-specific factors lead to rapid and extensive reprogramming. | Jullien J et al. | β | 2014 | β |
| hiPSC Modeling of Inherited Cardiomyopathies. | Jung G et al. | β | 2014 | β |
| How to make a cardiomyocyte. | SpΓ€ter D et al. | β | 2014 | β |
| Impaired neural differentiation potency by retinoic acid receptor-Ξ± pathway defect in induced pluripotent stem cells. | Hou PS et al. | β | 2014 | β |
| Induced neural lineage cells as repair kits: so close, yet so far away. | Mirakhori F et al. | β | 2014 | β |
| Induced pluripotency enables differentiation of human nullipotent embryonal carcinoma cells N2102Ep. | Sutiwisesak R et al. | β | 2014 | β |
| Induced Pluripotent Stem Cells Derived from Alzheimer's Disease Patients: The Promise, the Hope and the Path Ahead. | Freude K et al. | β | 2014 | β |
| Induced pluripotent stem cells for modeling of pediatric neurological disorders. | Jang J et al. | β | 2014 | β |
| Induced pluripotent stem cells in dermatology: potentials, advances, and limitations. | Bilousova G et al. | β | 2014 | β |
| Induced pluripotent stem cell transplantation in the treatment of porcine chronic myocardial ischemia. | Zhou Y et al. | β | 2014 | β |
| In vitro pre-vascularisation of tissue-engineered constructs A co-culture perspective. | Baldwin J et al. | β | 2014 | β |
| iPS cell-derived cardiogenicity is hindered by sustained integration of reprogramming transgenes. | Martinez-Fernandez A et al. | β | 2014 | β |
| Maintenance and neuronal differentiation of chicken induced pluripotent stem-like cells. | Dai R et al. | β | 2014 | β |
| Molecular control of induced pluripotency. | Theunissen TW et al. | β | 2014 | β |
| Molecular mechanisms of dopaminergic subset specification: fundamental aspects and clinical perspectives. | Veenvliet JV et al. | β | 2014 | β |
| Multicolor staining of globin subtypes reveals impaired globin switching during erythropoiesis in human pluripotent stem cells. | Ochi K et al. | β | 2014 | β |
| Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons. | Qi SD et al. | β | 2014 | β |
| Opportunities and Limitations of Modelling Alzheimer's Disease with Induced Pluripotent Stem Cells. | Ovchinnikov DA et al. | β | 2014 | β |
| Origin-dependent neural cell identities in differentiated human iPSCs in vitro and after transplantation into the mouse brain. | Hargus G et al. | β | 2014 | β |
| Physical developmental cues for the maturation of human pluripotent stem cell-derived cardiomyocytes. | Zhu R et al. | β | 2014 | β |
| Reduced immunogenicity of induced pluripotent stem cells derived from Sertoli cells. | Wang X et al. | β | 2014 | β |
| Regenerative Cell Therapy for Corneal Endothelium. | Bartakova A et al. | β | 2014 | β |
| Relationship of DNA methylation and gene expression in idiopathic pulmonary fibrosis. | Yang IV et al. | β | 2014 | β |
| Renal stem cell reprogramming: Prospects in regenerative medicine. | Morales EE et al. | β | 2014 | β |
| Reprogramming approaches in cardiovascular regeneration. | Dal-Pra S et al. | β | 2014 | β |
| Reprogramming cell fate: a changing story. | Chin MT | β | 2014 | β |
| Reprogramming for cardiac regeneration. | Raynaud CM et al. | β | 2014 | β |
| Reprogramming somatic cells to a kidney fate. | Takasato M et al. | β | 2014 | β |
| Role of biomechanical forces in stem cell vascular lineage differentiation. | Potter CM et al. | β | 2014 | β |
| Selection via pluripotency-related transcriptional screen minimizes the influence of somatic origin on iPSC differentiation propensity. | Hartjes KA et al. | β | 2014 | β |
| Self-renewal and cell lineage differentiation strategies in human embryonic stem cells and induced pluripotent stem cells. | Efthymiou AG et al. | β | 2014 | β |
| Somatic transcriptome priming gates lineage-specific differentiation potential of human-induced pluripotent stem cell states. | Lee JH et al. | β | 2014 | β |
| Stable methylation at promoters distinguishes epiblast stem cells from embryonic stem cells and the in vivo epiblasts. | Veillard AC et al. | β | 2014 | β |
| Stem cells: The quest for the perfect reprogrammed cell. | Krupalnik V et al. | β | 2014 | β |
| Strategies for Oral Mucosal Repair by Engineering 3D Tissues with Pluripotent Stem Cells. | Hewitt KJ et al. | β | 2014 | β |
| The developmental potential of iPSCs is greatly influenced by reprogramming factor selection. | Buganim Y et al. | β | 2014 | β |
| The osteoblast to osteocyte transition: epigenetic changes and response to the vitamin D3 hormone. | St John HC et al. | β | 2014 | β |
| The Potential for iPS-Derived Stem Cells as a Therapeutic Strategy for Spinal Cord Injury: Opportunities and Challenges. | Khazaei M et al. | β | 2014 | β |
| The potential of stem cell-based therapy for retinal repair. | Yu H et al. | β | 2014 | β |
| The Rho kinase inhibitor Y-27632 facilitates the differentiation of bone marrow mesenchymal stem cells. | Liu X et al. | β | 2014 | β |
| Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance. | de Almeida PE et al. | β | 2014 | β |